<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69353</article-id><article-id pub-id-type="doi">10.7554/eLife.69353</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>An XRCC4 mutant mouse, a model for human X4 syndrome, reveals interplays with Xlf, PAXX, and ATM in lymphoid development</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-235470"><name><surname>Roch</surname><given-names>Benoit</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-235471"><name><surname>Abramowski</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-235472"><name><surname>Etienne</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235473"><name><surname>Musilli</surname><given-names>Stefania</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235474"><name><surname>David</surname><given-names>Pierre</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235475"><name><surname>Charbonnier</surname><given-names>Jean-Baptiste</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235476"><name><surname>Callebaut</surname><given-names>Isabelle</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235477"><name><surname>Boussin</surname><given-names>François D</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-234241"><name><surname>de Villartay</surname><given-names>Jean-Pierre</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5987-0463</contrib-id><email>jean-pierre.de-villartay@inserm.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Université de Paris, Imagine Institute, Laboratory “Genome Dynamics in the Immune System”, INSERM UMR 1163, F-75015</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution>Equipe Labellisée Ligue Nationale Contre le Cancer, F75015</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution>Université de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, F-92265</institution><addr-line><named-content content-type="city">Fontenay-aux-Roses</named-content></addr-line><country>France</country></aff><aff id="aff4"><label>4</label><institution>Université de Paris, Imagine Institute, Transgenesis facility, INSERM UMR 1163, F-75015</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff5"><label>5</label><institution>Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, F-91198</institution><addr-line><named-content content-type="city">Gif-sur-Yvette Cedex</named-content></addr-line><country>France</country></aff><aff id="aff6"><label>6</label><institution>Sorbonne Université, Muséum National d'Histoire Naturelle, CNRS UMR 7590, Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie, F-75005</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sen</surname><given-names>Ranjan</given-names></name><role>Reviewing Editor</role><aff><institution>National Institute on Aging</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>14</day><month>09</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e69353</elocation-id><history><date date-type="received" iso-8601-date="2021-04-12"><day>12</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-09-13"><day>13</day><month>09</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Roch et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Roch et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69353-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-69353-figures-v2.pdf"/><abstract><p>We developed an <italic>Xrcc4<sup>M61R</sup></italic> separation of function mouse line to overcome the embryonic lethality of Xrcc4-deficient mice. XRCC4<sup>M61R</sup> protein does not interact with Xlf, thus obliterating XRCC4-Xlf filament formation while preserving the ability to stabilize DNA ligase IV. X4<sup>M61R</sup> mice, which are DNA repair deficient, phenocopy the <italic>Nhej1-/-</italic> (known as <italic>Xlf</italic> -/-) setting with a minor impact on the development of the adaptive immune system. The core non-homologous end-joining (NHEJ) DNA repair factor XRCC4 is therefore not mandatory for V(D)J recombination aside from its role in stabilizing DNA ligase IV. In contrast, <italic>Xrcc4<sup>M61R</sup></italic> mice crossed on <italic>Paxx-/-</italic>, <italic>Nhej1-/-</italic>, or <italic>Atm</italic>-/- backgrounds are severely immunocompromised, owing to aborted V(D)J recombination as in <italic>Xlf-Paxx</italic> and <italic>Xlf-Atm</italic> double Knock Out (DKO) settings. Furthermore, massive apoptosis of post-mitotic neurons causes embryonic lethality of <italic>Xrcc4<sup>M61R</sup> -Nhej1-/-</italic> double mutants. These in vivo results reveal new functional interplays between XRCC4 and PAXX, ATM and Xlf in mouse development and provide new insights into the understanding of the clinical manifestations of human <italic>XRCC4</italic>-deficient condition, in particular its absence of immune deficiency.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>adaptive immune system</kwd><kwd>non homologous end joining</kwd><kwd>v(d)j recombination</kwd><kwd>brain development</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001677</institution-id><institution>Institut National de la Santé et de la Recherche Médicale</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Roch</surname><given-names>Benoit</given-names></name><name><surname>Abramowski</surname><given-names>Vincent</given-names></name><name><surname>Musilli</surname><given-names>Stefania</given-names></name><name><surname>de Villartay</surname><given-names>Jean-Pierre</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-10-IAHU-01</award-id><principal-award-recipient><name><surname>Roch</surname><given-names>Benoit</given-names></name><name><surname>Abramowski</surname><given-names>Vincent</given-names></name><name><surname>Musilli</surname><given-names>Stefania</given-names></name><name><surname>David</surname><given-names>Pierre</given-names></name><name><surname>de Villartay</surname><given-names>Jean-Pierre</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006364</institution-id><institution>Institut National Du Cancer</institution></institution-wrap></funding-source><award-id>PLBIO 16-280</award-id><principal-award-recipient><name><surname>Roch</surname><given-names>Benoit</given-names></name><name><surname>Abramowski</surname><given-names>Vincent</given-names></name><name><surname>Musilli</surname><given-names>Stefania</given-names></name><name><surname>Charbonnier</surname><given-names>Jean-Baptiste</given-names></name><name><surname>Callebaut</surname><given-names>Isabelle</given-names></name><name><surname>de Villartay</surname><given-names>Jean-Pierre</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004099</institution-id><institution>Ligue Contre le Cancer</institution></institution-wrap></funding-source><award-id>Equipe Labellisée</award-id><principal-award-recipient><name><surname>Roch</surname><given-names>Benoit</given-names></name><name><surname>Abramowski</surname><given-names>Vincent</given-names></name><name><surname>Musilli</surname><given-names>Stefania</given-names></name><name><surname>de Villartay</surname><given-names>Jean-Pierre</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A viable separation of function <italic>XRCC4</italic> knock-in mutant mouse model recapitulates some aspects of <italic>XRCC4</italic> deficiency in humans, notably the absence of immune deficiency.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Living organisms face DNA double-strand breaks (DSBs), the most toxic DNA lesions, from random or programmed (prDSBs) origins (<xref ref-type="bibr" rid="bib10">Betermier et al., 2020</xref>), such as during the development of the adaptive immune system through V(D)J recombination. V(D)J recombination results in the somatic rearrangement of variable (V), diversity (D), and joining (J) elements of antigen receptor loci in T- and B-cell precursors (<xref ref-type="bibr" rid="bib28">Jung et al., 2006</xref>). It is initiated by the domesticated transposase Recombination-Activating Genes 1 and 2 factors (RAG1/2), which introduce prDSBs at the border of V, D, and J elements within recombination signal sequences (RSS). The non-homologous end-joining (NHEJ) machinery is the sole DNA repair pathway to cope with these lymphoid-specific prDSBs. Briefly, the NHEJ pathway is signaled by the Ataxia-Telangiectasia mutated (ATM) protein (<xref ref-type="bibr" rid="bib3">Arya and Bassing, 2017</xref>; <xref ref-type="bibr" rid="bib7">Bassing et al., 2002</xref>) and prompted by the Ku70-Ku80 complex that recognizes broken DNA ends and recruits the DNA-dependent protein kinase-catalytic subunit (DNA-PKcs), which further activates the pathway (<xref ref-type="bibr" rid="bib50">Sibanda et al., 2017</xref>). Broken DNA ends are processed by Artemis endo/exonuclease, which specifically opens the RAG1/2-generated hairpins at DNA ends during V(D)J recombination (<xref ref-type="bibr" rid="bib14">Chang et al., 2017</xref>). DNA ligase IV (Lig4), X-ray repair cross-complementation 4 (XRCC4, or X4), XRCC4-like factor (Xlf, also known as Cernunnos), and Paralog of XRCC4 and Xlf (PAXX) (<xref ref-type="bibr" rid="bib20">Craxton et al., 2015</xref>; <xref ref-type="bibr" rid="bib38">Ochi et al., 2015</xref>; <xref ref-type="bibr" rid="bib55">Xing et al., 2015</xref>) ensure ligation of broken ends (<xref ref-type="bibr" rid="bib35">Lieber, 2010</xref>). Lig4 and XRCC4 are critical factors during development apart from their essential function during V(D)J recombination, and both <italic>Lig4</italic>-/- and <italic>Xrcc4</italic>-/- mice suffer late embryonic lethality caused by apoptosis of post-mitotic neurons (<xref ref-type="bibr" rid="bib6">Barnes et al., 1998</xref>; <xref ref-type="bibr" rid="bib23">Frank et al., 1998</xref>; <xref ref-type="bibr" rid="bib49">Shull et al., 2009</xref>). Likewise, human patients with LIG4 syndrome present with dwarfism, microcephaly, and various degrees of immunodeficiency caused by hypomorphic mutations in the <italic>Lig4</italic> gene (<xref ref-type="bibr" rid="bib40">O’Driscoll et al., 2001</xref>; <xref ref-type="bibr" rid="bib51">Staines Boone et al., 2018</xref>).</p><p>In most of the cases, defects in core NHEJ factors result in severe combined immunodeficiency (SCID), owing to aborted V(D)J recombination both in humans and animal models (<xref ref-type="bibr" rid="bib21">de Villartay et al., 2003</xref>). NHEJ deficiency also results in genetic instability with the development of Pro-B cell lymphomas harboring chromosomal translocations when associated with <italic>Trp53-/-</italic> (<xref ref-type="bibr" rid="bib2">Alt et al., 2013</xref>). <italic>Xlf/Cernunnos</italic>-deficient patients also present with developmental features including dwarfism, microcephaly, and combined immunodeficiency (CID) (<xref ref-type="bibr" rid="bib12">Buck et al., 2006</xref>). However, V(D)J recombination is not severely affected nor in human (<xref ref-type="bibr" rid="bib12">Buck et al., 2006</xref>; <xref ref-type="bibr" rid="bib42">Recio et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">van der Burg and Gennery, 2011</xref>) or murine (<xref ref-type="bibr" rid="bib34">Li et al., 2008</xref>; <xref ref-type="bibr" rid="bib44">Roch et al., 2019</xref>; <xref ref-type="bibr" rid="bib54">Vera et al., 2013</xref>) settings of <italic>Xlf</italic> deficiency. This paradoxical situation is a consequence of the functional redundancy between Xlf and several DNA repair factors, including PAXX, ATM, H2A.X, MDC1, MRI, and 53BP1 as revealed by the complete V(D)J recombination defect in combined deficient settings (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Beck et al., 2019</xref>; <xref ref-type="bibr" rid="bib27">Hung et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Musilli et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Oksenych et al., 2012</xref>; <xref ref-type="bibr" rid="bib58">Zha et al., 2011</xref>) as well as RAG2 itself (<xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>). Consistent with their overall efficient V(D)J recombination, <italic>Nhej1-Trp53</italic> DKO mice indeed do not develop Pro-B cell lymphomas (<xref ref-type="bibr" rid="bib54">Vera et al., 2013</xref>).</p><p>To account for this functional redundancy, we proposed a model in which prDSBs may benefit from evolutionary conserved DNA repair mechanisms as to avoid their intrinsic oncogenic potential (<xref ref-type="bibr" rid="bib10">Betermier et al., 2020</xref>). In the particular context of V(D)J recombination, this mechanism would operate through a redundant ‘double DNA repair synapse,’ which strictly operates during V(D)J recombination to prevent genomic instability, but not in case of genotoxic-induced DNA damage (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>). The ‘two-synapses’ model accounts for the absence of V(D)J recombination defect in the absence of Xlf. One essential actor of the ‘two-synapses’ model is the RAG2 factor itself, which together with RAG1 is known to remain on DNA broken ends during V(D)J recombination, forming the so-called post-cleavage complex (PCC) (<xref ref-type="bibr" rid="bib48">Schatz and Swanson, 2011</xref>). We previously established that the C-terminus of RAG2 is determinant in complementing the lack of Xlf (<xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>). Indeed, the combined absence of the C-terminus of RAG2 and Xlf results in SCID mice owing to a complete block of V(D)J recombination. In the ‘two-synapses’ model, the first synapse would be mediated by RAG2, PAXX, and ATM signaling as suggested by efficient V(D)J recombination in multiply deficient v-Abl transformed Pro-B cells (<xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>; <xref ref-type="bibr" rid="bib33">Lescale et al., 2016b</xref>);. The second synapse is constituted by the Xlf-X4 filament or the <italic>bona fide</italic> NHEJ core complexes, the structure of which was recently resolved through cryoelectron microscopy (cryo-EM) (<xref ref-type="bibr" rid="bib15">Chaplin et al., 2021a</xref>; <xref ref-type="bibr" rid="bib16">Chaplin et al., 2021b</xref>; <xref ref-type="bibr" rid="bib59">Zhao et al., 2020</xref>). The V(D)J recombination-specific ‘two-synapses’ apparatus appears as a double-edged sword backup system to avoid genomic instability. Indeed, RAG2/Xlf double mutant mice develop typical NHEJ-deficient pro-B cell lymphomas when crossed onto a <italic>Trp53-/-</italic> background (<xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>).</p><p>One question remains as to the contribution of X4 in this model given that classical KO strategies do not allow to directly assess the function of X4 since its absence results <italic>de facto</italic> in a complete Lig4 deficiency. Reminiscent to the Xlf-deficient condition, human patients identified with <italic>X4</italic> mutations present DNA repair defect hallmarks, including dwarfism, microcephaly, increased cellular sensitivity to radiomimetic agents, but, strikingly, no immunodeficiency (<xref ref-type="bibr" rid="bib22">de Villartay, 2015</xref>; <xref ref-type="bibr" rid="bib47">Saito et al., 2016</xref>). The absence of noticeable immunophenotype argues for a dispensable role of X4 during V(D)J recombination, outside its general Lig4 stabilization function. It also interrogates the positioning of X4 within the ‘two-synapses’ model knowing its structural and functional relationship with Xlf (<xref ref-type="bibr" rid="bib13">Callebaut et al., 2006</xref>).</p><p>XRCC4 is a keystone factor, playing two independent roles. First, X4 stabilizes Lig4 through its C-terminal coiled-coil domain (<xref ref-type="bibr" rid="bib26">Grawunder et al., 1997</xref>). Indeed, Lig4 expression is abrogated in <italic>Xrcc4</italic> Knock Out (KO) models both in vivo and in vitro (<xref ref-type="bibr" rid="bib24">Gao et al., 1998</xref>). In addition, X4 and Xlf homodimers interact through their N-terminal globular head to form long polymeric ‘filaments’ (<xref ref-type="bibr" rid="bib43">Reid et al., 2015</xref>; <xref ref-type="bibr" rid="bib45">Ropars et al., 2011</xref>). X4-Xlf filaments generate a ‘DNA repair synapse’ to tether broken DNA ends (<xref ref-type="bibr" rid="bib11">Brouwer et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Reid et al., 2015</xref>). DNA-end synapsis is a central issue during NHEJ, and the recent development of in vitro single-molecule technologies has highlighted the dynamic formation of DNA end-to-end synapses (flexible/long range for DNA end tethering and close/short range for DNA ligation) in addition to the Xlf-X4 filament, in which the various core NHEJ DNA repair factors (Ku70/80, DNA-PKcs, Xlf, X4/L4, and PAXX) participate to various degrees, in particular the association of Xlf with both X4 and Ku (for a recent review, see <xref ref-type="bibr" rid="bib59">Zhao et al., 2020</xref>). Several studies recently reported on the details of the structural assembly of these complexes using cryo-EM, thus improving our understanding on the composition of these complexes as well as the dynamics of the transition between various states during NHEJ-mediated DNA repair (<xref ref-type="bibr" rid="bib15">Chaplin et al., 2021a</xref>; <xref ref-type="bibr" rid="bib16">Chaplin et al., 2021b</xref>; <xref ref-type="bibr" rid="bib59">Zhao et al., 2020</xref>). These studies support in particular the interaction of the L4X4 complex with that of Ku70/80 previously proposed by <xref ref-type="bibr" rid="bib19">Costantini et al., 2007</xref>. The V(D)J recombination phenotype of <italic>Nhej1</italic> KO mice would argue that the RAG2-mediated DNA tethering is also redundant with these DNA end-to-end synapses. Nevertheless, the intimate nature of DNA end joining during V(D)J recombination may not always strictly coincide with what we know for the repair of genotoxic DNA breaks, precisely because of the existence of the ‘two-synapses’ mechanism.</p><p>Since X4 is compulsory for Lig4 stabilization, <italic>Xrcc4</italic>-/- mice phenocopy <italic>Lig4</italic>-/- condition, with an embryonic lethality and SCID phenotype (<xref ref-type="bibr" rid="bib24">Gao et al., 1998</xref>). The embryonic lethality is rescued on <italic>Trp53-/-</italic> background, but the SCID resulting from a complete block of lymphocyte development remains (<xref ref-type="bibr" rid="bib25">Gao et al., 2000</xref>). Furthermore, <italic>Xrcc4</italic>-/-<italic>Trp53</italic>-/- DKO mice develop Pro-B cell lymphomas (<xref ref-type="bibr" rid="bib17">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib25">Gao et al., 2000</xref>). To avoid disrupting the critical Lig4 stabilization function of X4, we engineered a <italic>Xrcc4 knock-in</italic> (KI) mouse model harboring the M61R missense mutation that abrogates X4-Xlf interaction (<xref ref-type="bibr" rid="bib45">Ropars et al., 2011</xref>), while keeping the Lig4 interaction domain unperturbed. <italic>Xrcc4<sup>M61R</sup></italic> mice are viable attesting for the stabilization of functional Lig4, thus allowing the study of lymphocyte development. Introduced on <italic>Atm</italic>-/-, <italic>Paxx</italic>-/-, and <italic>Nhej1</italic>-/- backgrounds, the <italic>Xrcc4<sup>M61R</sup></italic> mutation allows to address the ‘two-synapses’ DNA repair model in V(D)J recombination, and to expand the picture of NHEJ apparatus in brain and lymphocyte development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Generation of <italic>X<sup>M61R</sup></italic> mice</title><p>X4 and Xlf interact through a hydrophobic interface, which is disrupted by the X4<sup>M61R</sup> substitution, thus resulting in the loss of X4-Xlf filament (<xref ref-type="bibr" rid="bib45">Ropars et al., 2011</xref>). We developed an <italic>Xrcc4<sup>M61R</sup></italic> KI mouse model through CRISPR/Cas9 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Homozygous <italic>Xrcc4<sup>M61R/M61R</sup></italic> mice (<italic>Xrcc4<sup>M61R</sup></italic> mice) were viable arguing against any harmful impact of the M61R substitution during embryonic development, as opposed to the embryonic lethality of <italic>Xrcc4</italic> KOs.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>X4 and Lig4 expression and impaired non-homologous end-joining (NHEJ) in <italic>Xrcc4<sup>M61R</sup></italic> mice.</title><p>(<bold>A</bold>) Schematic representation of CRISPR/Cas9-driven homologous recombination strategy to generated <italic>Xrcc4<sup>M61R</sup> knock-in</italic> mouse model. (<bold>B</bold>) 5′UTR to 3′UTR <italic>Xrcc4</italic> RT-PCR in mouse thymocyte extracts from four littermates. The lower transcript represents the splicing out of exon 3 as described (<xref ref-type="bibr" rid="bib24">Gao et al., 1998</xref>). (<bold>C</bold>) WB analysis from mouse whole tissue extracts. (<bold>D</bold>) Western blot (WB) analysis from mouse embryonic fibroblast (MEF) extracts. (<bold>E</bold>) WB analysis from mouse whole tissue extracts. WB were performed at least three times with two animals per genotypes. (<bold>F</bold>) MEFs’ sensitivity to DNA double-strand break (DSB)-inducing agent phleomycin. Statistical tests for <italic>Xrcc4<sup>M61R</sup></italic> vs. WT (gray *) and <italic>Xrcc4<sup>M61R</sup></italic> vs. <italic>Xrcc4-/-</italic> (black *). (<bold>G</bold>) Relative survival of CD3/CD28-activated mature T cells following irradiation and 4 hr recovery. Statistical analysis for <italic>Xrcc4<sup>M61R</sup></italic> vs. WT (gray *) and <italic>Xrcc4<sup>M61R</sup></italic> vs. <italic>Nhej1-/-</italic> (green *).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69353-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Nucleotide sequence of two Xrcc4 transcripts in <italic>Xrcc4<sup>M61R</sup></italic> mice.</title><p>(<bold>A</bold>) Sequence alignment of WT and upper/lower Xrcc4 transcripts (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) showing M61R and silent mutations on the full-length (upper) form and the splicing out of exon 3 on the lower form. (<bold>B</bold>) Nucleotide sequence traces of upper and lower Xrcc4 transcripts.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69353-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>X4<sup>M61R</sup> stabilizes Lig4</title><p>RT-PCR analysis of X4 mRNA expression unveiled two isoforms in M61R mutation-bearing cells (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The expression of the full-length transcript carrying the five mutations was reduced (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, upper band) and was accompanied by a shorter isoform (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, lower band). Sequencing this alternative transcript revealed the out-of-frame splicing-out of exon 3 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The same X4 transcript missing exon 3 was described in a previous <italic>Xrcc4</italic> KO mouse model (<xref ref-type="bibr" rid="bib25">Gao et al., 2000</xref>; <xref ref-type="bibr" rid="bib24">Gao et al., 1998</xref>). A subsequent attempt to generate <italic>Xrcc4<sup>M61R</sup></italic> KI mouse model using an ssODN template lacking the four silent mutations resulted in the same pattern of expression of the M61R allele (data not shown). At the protein level, X4 expression was barely detectable in spleen, brain, thymus, and mouse embryonic fibroblasts (MEFs) from <italic>Xrcc4<sup>M61R</sup></italic> mice as opposed to their homozygous WT counterparts (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). In summary, <italic>Xrcc4<sup>M61R</sup></italic> mice express two X4 transcripts, one lacking exon 3 and resulting in a complete loss of function, and a second, full length, harboring the M61R missense variant encoding a weakly expressed X4 protein lacking its ability to interact with Xlf. Of note, Lig4 protein was readily detectable by WB in protein lysates from <italic>Xrcc4<sup>M61R</sup></italic> mice spleen and thymus, attesting for its stabilization by the X4<sup>M61R</sup> protein (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p><p>We conclude that the <italic>Xrcc4<sup>M61R</sup></italic> mouse model represents a hypomorphic condition in which the X4<sup>M61R</sup> protein, although weakly expressed, retains the capacity to stabilize Lig4 and thus ensures proper embryonic development with viable animals at birth.</p></sec><sec id="s2-3"><title>DSB repair defect in X4<sup>M61R</sup> cells</title><p>MEFs from <italic>Xrcc4<sup>M61R</sup></italic> mice presented a statistically significant decrease in cell viability compared to WT cells upon phleomycin, a DSB inducer, treatment, attesting for a profound DNA repair defect (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Likewise, splenic T cells from <italic>Xrcc4<sup>M61R</sup></italic> mice showed an increased IR sensitivity with an almost complete loss of viability at 2 Gy (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). These experiments demonstrate that the X4<sup>M61R</sup> mutant protein, which preserves the stabilization of Lig4, is nevertheless impaired in its capacity to achieve full repair of DSB introduced by random genotoxic agents.</p></sec><sec id="s2-4"><title>Lymphocyte development in <italic>Xrcc4<sup>M61R</sup></italic> mice phenocopies that of <italic>Nhej1</italic>-/- mice</title><p>We analyzed the impact of X4<sup>M61R</sup> substitution on T cell development in the thymus. Thymocyte counts were significantly reduced in <italic>Xrcc4<sup>M61R</sup></italic> thymus (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), but remained in the range of <italic>Nhej1</italic>-/- thymus cellularity (respectively [*10<sup>6</sup>] 26.8 ± 2.6 SEM vs. 115 ± 15 SEM in WT, p&lt;0.0001, vs. 12.5 ± 2.6 SEM in <italic>Nhej1</italic>-/-, ns). The thymocyte maturation program, identified through the various CD4/CD8 stages, was similar in <italic>Xrcc4<sup>M61R</sup></italic> and WT littermates (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), yet with a mild accumulation of CD44-CD25+ CD28- DN3A <italic>Xrcc4<sup>M61R</sup></italic> thymocytes (respectively 81.8% ± 0.9 SEM vs. 76.1% ± 0.7 SEM, p&lt;0.0001) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), a trait shared by thymocytes from <italic>Nhej1</italic>-/- mice (81.1% ± 1.4 SEM) as described (<xref ref-type="bibr" rid="bib44">Roch et al., 2019</xref>). Purified <italic>Xrcc4<sup>M61R</sup></italic> thymocytes presented an increased apoptosis (7AAD+/AnnV+), similar to that of <italic>Nhej1-/-</italic> thymocytes (respectively 47.4% ± 1.7 SEM vs. 33.2% ± 1.3 SEM for WT, p=0.0003, vs. 59.5% ± 1.6 SEM, for <italic>Nhej1-/-</italic>, ns) (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). This was accompanied by the expression of TP53 target genes <italic>Cdkn1a</italic>, <italic>Bbc3,</italic> and <italic>Bax,</italic> in both <italic>Xrcc4<sup>M61R</sup></italic> and <italic>Nhej1-/-</italic> thymocytes (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Lastly, TCRα repertoire was skewed in <italic>Xrcc4<sup>M61R</sup></italic> thymocytes (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), with the decreased usage of distal VαJα rearrangements, a hallmark of reduced thymocyte viability or suboptimal V(D)J recombination.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Xrcc4<sup>M61R</sup></italic> mice exhibit modest T cell development defect in the thymus phenocopying <italic>Nhej1-/-</italic> mice.</title><p>(<bold>A</bold>) Thymus cellularity of WT, <italic>Xrcc4<sup>M61R</sup></italic>, and <italic>Nhej1-/-</italic> (Xlf) 6–9-week-old mice. (<bold>B</bold>) Immunostaining of thymus cellular populations. Various relevant populations are highlighted in black gates. (<bold>C</bold>) Quantification of DN3A thymocyte subpopulation (DN3 CD28-CD25+) gated from total DN3 thymocytes (CD4-CD8-CD44-CD25+). (<bold>D</bold>) Thymocyte apoptosis analysis after 20 hr of culture. AnnexinV+/7AAD+ apoptotic cells are highlighted in black gates. (<bold>E</bold>) Quantification of thymocyte apoptosis (AnnexinV+/7AAD+ cells) after 20 hr of culture. (<bold>F</bold>) Quantitative RT-PCR analysis of TP53 target genes <italic>Cdkn1a</italic> (encoding P21), <italic>Bbc3</italic> (encoding PUMA), and <italic>Bax</italic> in thymocyte extracts. There is no statistical difference between <italic>Xrcc4<sup>M61R</sup></italic> and <italic>Nhej1-/-</italic> in the expression of these TP53 target genes. (<bold>G</bold>) Illustrative representation of principal component analysis/unsupervised hierarchical clustering (PCA/HC) analysis of mTRAJ-mTRAV combinations in thymus according to PROMIDISα. (<bold>H</bold>) Immunostaining of bone marrow cellular populations. V(D)J recombination-dependent developmental stages are highlighted within red rectangles. Various relevant populations are highlighted in black gates. Quantification of B-cell population (B220+) (<bold>I</bold>) and immature B-cell population (CD19+ B220+ IgM+) (<bold>J</bold>) from total bone marrow.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69353-fig2-v2.tif"/></fig><p>The proportion of mature B lymphocytes in the bone marrow (BM) was not significantly altered in <italic>Xrcc4<sup>M61R</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2H, I</xref>), while significantly decreased in <italic>Nhej1-/-</italic> mice (respectively 21.7% ± 1.8 SEM vs. 26.0% ± 1.1 SEM, ns, vs. 13.3% ± 0.6 SEM, p=.008). However, the proportions of immature B cells were decreased in <italic>Xrcc4<sup>M61R</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2J</xref>), close to the already described decline of <italic>Nhej1-/-</italic> immature B cells (respectively 11.3% ± 3.3 SEM vs. 19.3% ± 2.6 SEM, p=0.0002, vs. 8.7% ± 2.5 SEM, ns).</p><p>These results indicate that B- and T-lymphocyte development is not severely affected in <italic>Xrcc4<sup>M61R</sup></italic> mice, despite the reduced expression of X4<sup>M61R</sup>. The minor accumulation of DN3A thymocytes and immature B cells suggests a modest decreased V(D)J recombination efficiency, supported by the bias in TCRα usage. This is in sharp contrast with <italic>Xrcc4</italic>-/- and <italic>Lig4</italic>-/- mice, which present a complete arrest of lymphocyte maturation and a SCID phenotype. We conclude that when Lig4 is stabilized, the contribution of X4 through Xlf/X4 interaction, disrupted in the context of X4<sup>M61R</sup>, is not critical for V(D)J recombination in vivo.</p></sec><sec id="s2-5"><title>PAXX and ATM are compensatory factors for X4 in lymphoid development</title><p>We previously proposed a model of ‘double DNA repair synapse’ during V(D)J recombination according to which the X4-Xlf ‘filament’ and the RAG1/2 PCC, together with ATM and PAXX, provide two complementary means of DNA end synapsis (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Betermier et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>). To address the role of X4 in this model, we crossed <italic>Xrcc4<sup>M61R</sup></italic> onto <italic>Paxx</italic>-/- and <italic>Atm</italic>-/- mice (hereafter denoted as <italic>Xrcc4<sup>M61R</sup>-Paxx</italic> and <italic>Xrcc4<sup>M61R</sup>-Atm</italic>). Both double mutant mice were viable but exhibited severe growth retardation and facial dysmorphia as a consequence of either the X4<sup>M61R</sup> mutation and/or the overall reduction in X4/L4 expression (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><p>The thymus and spleen cellularity was severely reduced in both <italic>X4<sup>M61R</sup>-Paxx</italic> and <italic>Xrcc4<sup>M61R</sup>-Atm</italic> mice (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>) as compared to their <italic>Xrcc4<sup>M61R</sup></italic> single-mutant littermates (respectively [*10<sup>6</sup>] 1.1 ± 0.2 SEM and 0.56 ± 0.15 SEM, p&lt;0.0001, vs. 26.8 ± 2.6 SEM in thymus and 6.8 ± 1.2 SEM and 4.1 ± 1.0 SEM, p&lt;0.0001, vs. 40.0 ± 3.8 SEM in spleen), and previously described Atm and Paxx single KO conditions (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>). B cells expressing IgM were undetectable in BM from <italic>Xrcc4<sup>M61R</sup>-Atm</italic> mice and to a lesser extent in <italic>Xrcc4<sup>M61R</sup>-Paxx</italic> mice (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). B220+ B cells were strongly reduced compared to <italic>Xrcc4<sup>M61R</sup></italic> or WT littermates in both settings (respectively 10.9% ± 1.4 SEM and 7.2% ± 0.96 SEM, p=0.001, vs. 21.7 ± 1.79 SEM in <italic>Xrcc4<sup>M61R</sup></italic> and 26.3 ± 1.08 SEM in WT) (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Likewise, <italic>Xrcc4<sup>M61R</sup>-Paxx</italic> and <italic>X4<sup>M61R</sup>-Atm</italic> mice presented with a substantial accumulation of DN3A thymocytes (93.4% ± 0.8 SEM and 98.2% ± 0.3 SEM, p=0.0001, respectively, vs. 76.1 ± 0.7 SEM in WT), which was significantly greater than the one observed for <italic>Xrcc4<sup>M61R</sup></italic> (81.77 ± 1.4 SEM) or <italic>Nhej1-/-</italic> (81.1 ± 1.4 SEM) animals (<xref ref-type="fig" rid="fig3">Figure 3E</xref> and <xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>). The immune phenotype of <italic>Xrcc4<sup>M61R</sup>-Paxx</italic> and <italic>X4<sup>M61R</sup>-Atm</italic> mice is highly reminiscent of the SCID condition experienced by <italic>Nhej1-Paxx</italic>, <italic>Nhej1-Atm</italic>, and <italic>Nhej1-Rag2<sup>c/c</sup></italic> DKO mice (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>; <xref ref-type="bibr" rid="bib37">Musilli et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Zha et al., 2011</xref>) and suggested a possible impaired V(D)J recombination in these double mutants. Indeed, while Dβ<sub>2</sub>-Jβ<sub>2</sub> (upper panel) and Vβ<sub>10</sub>-Dβ<sub>2</sub>Jβ<sub>2</sub> (lower panel) rearrangements of the <italic>Tcrb</italic> locus were present in thymocytes from <italic>Xrcc4<sup>M61R</sup></italic>, <italic>Atm</italic>-/-, and WT mice (Figure 3F and G), as also previously observed in <italic>Paxx-/-</italic> mice (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>), they were barely detectable in DNA from <italic>Xrcc4<sup>M61R</sup>-Paxx</italic> and <italic>Xrcc4<sup>M61R</sup>-Atm</italic> thymus.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>PAXX and ATM are compensatory factors of X4<sup>M61R</sup> in immune development.</title><p>(<bold>A, B</bold>) Thymus and spleen cellularity of WT, <italic>Xrcc4<sup>M61R</sup></italic>, <italic>Xrcc4<sup>M61R</sup>–Paxx,</italic> and <italic>Xrcc4<sup>M61R</sup>–Atm</italic> 6–9-week-old mice. (<bold>C</bold>) Immunostaining of BM and thymus cellular populations. Various relevant populations are highlighted in black gates. (<bold>D</bold>) Quantification of B220+ subpopulation of total BM. (<bold>E</bold>) Quantification of DN3A thymocyte subpopulation (DN3 CD28-CD25+) of total DN3 thymocytes (CD4-CD8-CD44-CD25+). (<bold>F</bold>) Schematic representation of PCR strategy to analyze <italic>Tcrb</italic> rearrangement according to <xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>. (<bold>G</bold>) Autoradiogram of ladder of productive Dβ<sub>2</sub>-Jβ<sub>2</sub> and Vβ<sub>10</sub>-Dβ<sub>2</sub>Jβ<sub>2</sub> semi-quantitative PCR products revealed by the TCR-Jβ probe. Genomic DNA dilutions are represented with triangles. Germline allele configuration (GL) is revealed by the upper band of Dβ<sub>2</sub>-Jβ<sub>2</sub> PCR. Southern were performed twice with two animals per genotype.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69353-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Growth retardations of <italic>Xrcc4<sup>M61R</sup>-Paxx</italic> and <italic>Xrcc4<sup>M61R</sup>-Atm</italic> mice.</title><p>(<bold>A–C</bold>) Photographs of 7-week-old littermates.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69353-fig3-figsupp1-v2.tif"/></fig></fig-group><p>We conclude that <italic>Xrcc4<sup>M61R</sup></italic> crossed on <italic>Paxx</italic>-/- or <italic>Atm</italic>-/- phenocopy the SCID phenotype of <italic>Nhej1-Paxx</italic> and <italic>Nhej1-Atm</italic> DKO conditions owing to impaired V(D)J recombination. Therefore, aside from its essential role in Lig4 stabilization, X4 does participate in DNA coding-end tethering through its interaction with Xlf during V(D)J recombination, and PAXX/ATM are compensatory factors for this later function in vivo, as they are for Xlf. Alternatively, one may consider that the Xlf function being impaired in the context of X4<sup>M61R</sup>, PAXX/ATM complements this defect as already established.</p></sec><sec id="s2-6"><title>Impaired brain development and immune deficiency in <italic>Xrcc4<sup>M61R</sup> Nhej1-/-</italic> mice</title><p>To further assess the function of X4<sup>M61R</sup> in vivo, we introduced <italic>Xrcc4<sup>M61R</sup></italic> on <italic>Nhej1-/-</italic> background. No <italic>Xrcc4<sup>M61R</sup>-Nhej1-/-</italic> double homozygous mice (hereafter named as <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic>) could be recovered out of 166 newborns obtained from various genotype combinations, when 23 were expected (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), testifying the lethality of <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> embryos. Nevertheless, lived <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> fetuses could be recovered at E15.5 and E18.5. They were smaller than their <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic>+/- littermates, confirming abnormal development (<xref ref-type="fig" rid="fig4">Figure 4B</xref> and data not shown). This is reminiscent of the late embryonic lethality of <italic>Lig4</italic>-/-, <italic>Xrcc4</italic>-/-, and <italic>Nhej1-Paxx</italic> DKO mice (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib4">Balmus et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Frank et al., 1998</xref>; <xref ref-type="bibr" rid="bib24">Gao et al., 1998</xref>; <xref ref-type="bibr" rid="bib36">Liu et al., 2017</xref>). Massive neuronal apoptosis was detected in E15.5 brain slices through cleaved-caspase 3 (CC3) staining in upper layers of dorsal telencephalon corresponding to the intermediate zone (IZ) and the cortical plate (CP) in <italic>Xrcc4<sup>M61R-</sup>Nhej1</italic> mice (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>). The IZ contains post-mitotic neurons migrating to populate the CP, while neural progenitors proliferate in lower layers: the ventricular zone (VZ) and sub-ventricular zone (SVZ). Thus, <italic>Xrcc4<sup>M61R-</sup>Nhej1</italic> embryonic lethality recapitulates, although to a lesser extent, the massive post-mitotic neuron apoptosis observed in <italic>Nhej1-Paxx</italic> DKO and <italic>Xrcc4</italic>-/- brains (<xref ref-type="fig" rid="fig4">Figure 4C and E</xref>), which causes the previously described embryonic lethality of these conditions. In contrast, <italic>Nhej1-/-</italic> and <italic>Xrcc4<sup>M61R</sup></italic> single mutants showed modest increases of CC3 staining (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>), while we showed previously that <italic>Paxx</italic>-/- are indistinguishable from WT (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Embryonic lethality and neuronal apoptosis of <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> embryos.</title><p>(<bold>A</bold>) Impaired development of <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> mice. Actual and expected numbers of <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> alive pups, E18.5 and E15.5 embryos. (<bold>B</bold>) Pictures of <italic>Xrcc4<sup>M61R</sup></italic> and <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> E15.5 embryos. (<bold>C</bold>) Cleaved-caspase 3 (CC3, red) immunostaining of E15.5 brain slices. Scarce apoptotic cells are detected in the whole dorsal telencephalon from <italic>Nhej1-/-</italic> and <italic>Xrcc4<sup>M61R</sup></italic> embryos. By contrast, massive neuronal apoptosis is observed in the upper layers of the developing cortex of <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic>, <italic>Xrcc4-/-,</italic> and <italic>Nhej1-Paxx</italic> DKO embryos. The white boxes indicate the location of the standard window (100 µm wide) spanning from the ventricular to pial surface used to quantify pyknotic nuclei in the dorsal telencephalons (see below). Scale bar: 100 µm. (<bold>D</bold>) Number of CC3-positive cells in the VZ/SVZ (black)—containing the cycling neural progenitors—and intermediate zone (IZ)/cortical plate (CP) (gray)—containing post-mitotic neurons—of the whole dorsal telencephalons from WT, <italic>Nhej1-/-,</italic> and <italic>Xrcc4<sup>M61R</sup></italic> embryos. (<bold>E</bold>) Percentage of apoptotic (pyknotic) nuclei in the ventricular zone (VZ)/sub-ventricular zone (SVZ) (left panel) and the IZ/CP (right panel) found in the standard windows shown in (<bold>C</bold>). Data were obtained from both hemispheres of three embryos per condition.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69353-fig4-v2.tif"/></fig><p>We next analyzed the adaptive immune system development of <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> fetuses. B-lymphocyte development begins at E17.5 in the fetal liver (FL), with the rearrangement of the <italic>Igh</italic> locus and the intracellular expression of Ig-μH chains in CD19+ B220+ CD43+ Pro B cells, which is used as a proxy to evaluate <italic>Igh</italic> rearrangement completion (<xref ref-type="bibr" rid="bib29">Kajikhina et al., 2016</xref>). <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> Pro-B cells failed to express intracellular μH chain when compared to WT (0.90% ± 0.09 SEM, p=0.008), which contrasted with the slight reduction observed in <italic>Xrcc4<sup>M61R</sup></italic> and <italic>Nhej1-/-</italic> mice (respectively 16.6% ± 1.2 SEM and 19.1% ± 2.2 SEM vs. 32.8% ± 1.3 SEM, p=0.0016) (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>), arguing for a severe block in B cell maturation at Pro-B cell stage in <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> mice. Fetal thymocytes development of <italic>Xrcc4<sup>M61R</sup></italic> and <italic>Nhej1-/-</italic> mice recapitulated young adult thymus phenotype with a modest block at DN3A stage compared to WT (respectively 83.3% ± 2.7 SEM and 86.2 ± 2.2 SEM vs. 70.3% ± 1.1 SEM, p=0.0004). In contrast, <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> thymocyte development was severely compromised from the DN3A stage on when compared to <italic>Xrcc4<sup>M61R</sup></italic> and <italic>Nhej1-/-</italic> (99.4% ± 0.13 SEM, p=0.0007), and DP thymocytes or mature T cells were virtually absent from these thymii (<xref ref-type="fig" rid="fig5">Figure 5A and C</xref>). Dβ<sub>2</sub>-Jβ<sub>2</sub> and Vβ<sub>10</sub>-Dβ<sub>2</sub>Jβ<sub>2</sub> <italic>Tcrb</italic> genes rearrangements, which begin at around E13 (<xref ref-type="bibr" rid="bib41">Ramond et al., 2014</xref>), were undetectable in <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> thymus, while readily observed in WT, <italic>Xrcc4<sup>M61R</sup></italic>, and <italic>Nhej1-/-</italic> mice (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>), further attesting for an acute V(D)J recombination defect in <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> cells.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Complete V(D)J recombination defect in E18.5 <italic>Xrcc4<sup>M61R</sup>-Xlf</italic> embryos.</title><p>(<bold>A</bold>) Immunostaining of E18.5 fetal CD19+ B220+ CD43+ hepatocytes and fetal thymocytes. Various relevant populations are highlighted in black gates. (<bold>B</bold>) Quantification of <italic>intracellular</italic> IgM expression in subpopulation of fetal Pro-B cells (CD19+ B220+ CD43+ <italic>surface</italic>IgM- hepatocytes). (<bold>C</bold>) Quantification of DN3A thymocyte subpopulation (DN3 CD28-CD25+) of total DN3 fetal thymocytes (CD4-CD8-CD44-CD25+). (<bold>D</bold>) Schematic representation of PCR strategy to analyze <italic>Tcrb</italic> rearrangement according to <xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>. (<bold>E</bold>) Autoradiogram of ladder of productive Dβ<sub>2</sub>-Jβ<sub>2</sub> and Vβ<sub>10</sub>-Dβ<sub>2</sub>Jβ<sub>2</sub> direct PCR products revealed by the TCR-Jβ probe. Germline allele configuration (GL) is revealed by the upper band of Dβ<sub>2</sub>-Jβ<sub>2</sub> PCR. Southern was performed once with two animal per genotype.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69353-fig5-v2.tif"/></fig><p>Altogether, <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> embryonic development phenocopy <italic>Nhej1-Paxx</italic> DKO, with a profound defect in V(D)J recombination and the apoptosis of post-mitotic neurons leading to embryonic lethality.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We created an <italic>Xrcc4</italic> separation of function allele in mice, which harbor the M61R substitution previously described to abolish X4-Xlf interaction (<xref ref-type="bibr" rid="bib45">Ropars et al., 2011</xref>). The X4<sup>M61R</sup> protein, although weakly expressed, preserves the stabilization of Lig4 but severely compromises the NHEJ DNA repair function in affected mice. Nevertheless, <italic>Xrcc4<sup>M61R</sup></italic> mice are viable, arguing that the embryonic lethality of <italic>Xrcc4</italic> KO mice is most likely the result of the <italic>de facto</italic> absence of Lig4 in this setting, thus phenocopying <italic>Lig4</italic> KO condition. Interestingly, this also indicates that the formation of the X4-Xlf filament, abrogated by the M61R mutation, is dispensable for post-mitotic neuron viability, the loss of which causes lethality in <italic>Xrcc4</italic> and <italic>Lig4</italic> KO settings.</p><p>Immune development of <italic>Xrcc4<sup>M61R</sup></italic> mice phenocopied that of <italic>Nhej1-/-</italic> animals, with a slight decreased thymic cellularity, an increased thymocyte apoptosis, and skewed TCRα repertoire, which we previously linked to a suboptimal <italic>Tcra</italic> rearrangement efficiency (<xref ref-type="bibr" rid="bib9">Berland et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Roch et al., 2019</xref>; <xref ref-type="bibr" rid="bib54">Vera et al., 2013</xref>). In addition to their TCRα repertoire bias, <italic>Xrcc4<sup>M61R</sup></italic> thymocytes also faced a developmental delay at DN3A both in fetal and adult thymus like <italic>Nhej1</italic> KO condition, further attesting for a suboptimal V(D)J recombination activity in these mice. Therefore, although X4 is required for V(D)J recombination through Lig4 stabilization, it is not mandatory for coding-ends tethering during V(D)J recombination. These results confirm that X4 exerts a Lig4-independent function through its interaction with Xlf that is decisive for the repair of genotoxic-induced DSBs but compensated for by other DNA repair factors, and possibly RAG2 itself as shown for Xlf (<xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>), during V(D)J recombination. <italic>Xrcc4<sup>M61R</sup>–Paxx</italic> and <italic>Xrcc4<sup>M61R</sup>–Atm</italic> double homozygous mice were severely immunocompromised, owing to aborted V(D)J recombination, as noticed in <italic>Nhej1-Paxx</italic> and <italic>Nhej1-Atm</italic> DKO. We conclude that PAXX and ATM are compensatory factors for X4<sup>M61R</sup> during V(D)J recombination. This result further supports our previously proposed model of ‘double DNA repair synapse’ in V(D)J recombination, mediated by the X4-Xlf and RAG2-PAXX-ATM axes, respectively (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Betermier et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Lescale et al., 2016a</xref>). In addition to their defect in V(D)J recombination, <italic>Xrcc4<sup>M61R</sup>-Nhej1</italic> double homozygous mice were embryonic lethal owing to massive post-mitotic neuron apoptosis, recapitulating <italic>Xrcc4</italic>-/- setting. This observation may be the result of the lower expression of the X4<sup>M61R</sup> protein, which could have additive/synthetic effects with the loss of Xlf interaction during NHEJ. Indeed, <italic>Nhej1</italic> deficiency causes synthetic lethality with several other NHEJ-deficient conditions, such as <italic>Prkdc</italic>-/-, <italic>Mri</italic>-/-, <italic>H2ax</italic>-/-, and <italic>Paxx</italic>-/- (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Hung et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Xing et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Zha et al., 2011</xref>). Therefore, Xlf can rescue very different NHEJ defects, through an unknown mechanism, perhaps in relation with recovery of replication fork stalling as shown in the <italic>Nhej1-H2ax</italic> DKO mice (<xref ref-type="bibr" rid="bib18">Chen et al., 2019</xref>).</p><p>Altogether, the <italic>Xrcc4<sup>M61R</sup></italic> separation of function allele highlights for the first time at least two independent roles of X4 in NHEJ and establishes that X4 is not mandatory for coding ends tethering during V(D)J recombination. This study also unravels novel interplays between X4, PAXX, ATM, and Xlf during development of the brain and the immune system.</p><p>Several deleterious mutations in the <italic>XRCC4</italic> gene have been reported in humans (see <xref ref-type="bibr" rid="bib22">de Villartay, 2015</xref> for review), most of which are associated with microcephalic primordial dwarfism (MPD), gonadal failure, early-onset metabolic syndrome, and cardiomyopathies. The DNA repair deficiency in these patients is manifest when tested in vitro retrospectively. Most surprisingly however, they do not present noticeable signs of immune dysfunction. Altogether, the clinical presentation of these patients was not evocative of an impaired NHEJ given the known impact of its deficiency on the development of the adaptive immune system. Indeed, <italic>X4</italic> mutations were not identified in these patients through hypothesis-driven candidate gene sequencing but rather through unsupervised whole-exome sequencing. Our present study now provides some hints as to explain the absence of immunological features in <italic>X4</italic>-deficient patients; when Lig4 expression is spared to some extent by hypomorphic mutations, allowing birth, XRCC4 appears not critically required for the development of the adaptive immune system.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p><italic>Nhej1-/-</italic> (<xref ref-type="bibr" rid="bib54">Vera et al., 2013</xref>), <italic>Paxx</italic>-/- (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>), <italic>Xrcc4</italic>-/- (<xref ref-type="bibr" rid="bib24">Gao et al., 1998</xref>), and <italic>Atm</italic>-/- (<xref ref-type="bibr" rid="bib5">Barlow et al., 1996</xref>) mice were maintained in pathogen-free environment. All experiments were performed in compliance with the French Ministry of Agriculture’s regulations for animal experiments (act 87847, 19 October 1987; modified in May 2001).</p><p>The <italic>Xrcc4<sup>M61R</sup></italic> allele was generated through CRISPR/cas9 ribonucleoprotein (RNP) complex microinjection in C57BL/6J mouse zygotes pronuclei as described (<xref ref-type="bibr" rid="bib52">Ucuncu et al., 2020</xref>). <italic>Xrcc4</italic> exon 3-specific gRNA (5′-<named-content content-type="sequence">GTACCAGCTGCTCCTGACCC</named-content>-3′) was designed using Crispor (<ext-link ext-link-type="uri" xlink:href="http://crispor.tefor.net/oligonucleotide">http://crispor.tefor.net/oligonucleotide</ext-link>). The HR template was the ssODN ([Integrated DNA technologies, IDT] 5′-<named-content content-type="sequence">TCAAGGGAGAAATGCCGAGACTCCTTAGAAAAGAGGAACTTGTATGTACCAGCaGCACCGGAGCCTGGCACCAGTGCCTTTCTCAGCTCATCAATGTATTTTCCTTTCTCCCTAGCCATGTCATCAGCTTCTTGGGAAATCTCCAATTCAGAAACTATGGGAAAGATTAATTAAGGTGAT</named-content>-3′; see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). F° chimera screen and <italic>Xrcc4<sup>M61R</sup></italic> mice genotyping were obtained upon FspBI digestion of genomic DNA amplified with primers F 5′-<named-content content-type="sequence">AGGAGACGGAGGAAAAAGAGATG</named-content>-3′ and R 5′-<named-content content-type="sequence">TACCCTCACAGAAACACAACTCA</named-content>-3′.</p></sec><sec id="s4-2"><title>Immunoblotting</title><p>Whole tissues or MEFs single-cell suspensions were washed in PBS. Cells were lysed in 50–200 μL of 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% TritonX100, 1X phosphatase inhibitor cocktail 2 and 3 (ThermoFisher), and 1X protease inhibitor cocktail EDTA free (Roche) on ice for 45 min. Proteins migrated within Tris-Acrylamide gels and Tris-Glycine-SDS buffer and were transferred on PVDF membranes (Immobilon). Membranes were stained with the following antibodies: β-actin (mouse monoclonal AM4302, ThermoFisher), XRCC4 (goat monoclonal C-20, Santa Cruz), and DNA ligase IV (mouse monoclonal D-8, Santa Cruz). Membranes were revealed with appropriate secondary antibodies conjugated with infrared 700 or 800 dyes (LiCor). Immunoblotting was revealed by LiCor CLx analyzer and analyses were performed on Image Studio Lite software.</p></sec><sec id="s4-3"><title>X4 transcript analysis</title><p>Total RNAs were obtained from thymocytes with Pure Like RNA mini kit (Invitrogen) and used for RT-PCR (SuperScript II reverse transcriptase; Invitrogen). X4 transcripts were amplified with primers F1 5′-<named-content content-type="sequence">TTGGGCGCATCGGTTTATCT</named-content>-3′ R1 5′-<named-content content-type="sequence">GCTGCTAAGTTGAAAGCCTG</named-content>-3′ F2 5′-<named-content content-type="sequence">TGCTTCTGAACCCAACGTACC</named-content>-3′ R2 5′- <named-content content-type="sequence">AGGTGCTCGTTTTTGGCTTG</named-content>-3′. F1-R1 PCR amplifies full-length transcript from 5′UTR to 3′UTR (1150 bp) and F2-R2 amplifies exon 2 to exon 4 (400 bp).</p></sec><sec id="s4-4"><title>Flow cytometry analysis of cell populations</title><p>Cell phenotyping from 6- to 9-week-old mice was performed on thymus, spleen, and bone marrow using the following antibodies: CD4, CD8, CD25, CD28, CD44, CD69, B220, CD19, CD43, and IgM (all from Sony Biotechnology, using respectively PECy7, FITC, PerCPCy5.5, PE, BV510, APC, PE, PECy7, FITC, APC fluorophores). Intracellular IgM expression in E18.5 FL cells was performed as previously described (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>) using CD19, B220, CD43, IgM for extracellular staining followed by cell fixation and permeabilization (Invitrogen) and intracellular IgM staining (all antibodies from Sony Biotechnology, using respectively PECy7, BV605, PE, FITC, and APC). Cells were recorded by FACS LSR-Fortessa X-20 and analyses were performed with FlowJo 10 software.</p></sec><sec id="s4-5"><title>Cellular sensitivity to DSBs-inducing agents and thymocyte survival assay</title><p>For phleomycin sensitivity assay, 5000 MEF cells were seeded in triplicates and cultivated with increasing doses (0–300 ng/mL) of phleomycin. Living cells were counted by flow analysis with FACS LSR-Fortessa X-20 after 6 days of culture. Radiation sensitivity of T lymphocytes was performed as described (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>). Ex vivo thymocyte survival assay was performed as described (<xref ref-type="bibr" rid="bib54">Vera et al., 2013</xref>).</p></sec><sec id="s4-6"><title>Quantitative real-time RT-PCR analysis</title><p>TaqMan PCR was performed on triplicates of 8 ng of reverse-transcribed RNA from freshly dissected total thymus as described (<xref ref-type="bibr" rid="bib54">Vera et al., 2013</xref>).</p></sec><sec id="s4-7"><title>Analysis of thymic TCR-alpha repertoire</title><p>Comprehensive TCR-alpha repertoire analyses were performed by 5′ Rapid amplification of complementary DNA (cDNA) ends (5′RACE) PCR/NGS (switching mechanism at the 5′end of the RNA transcript, SMARTα) from total thymus RNA as described (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Roch et al., 2019</xref>; <xref ref-type="bibr" rid="bib54">Vera et al., 2013</xref>). Sequencing data were analyzed with LymAnalyzer (<xref ref-type="bibr" rid="bib57">Yu et al., 2016</xref>) to retrieve unique CDR3 clonotypes and determine T cell receptor alpha variable (TRAV) and T cell receptor alpha junction (TRAJ) gene segments. Frequencies of TRAV and TRAJ usage were implemented in principal component analysis (PCA) and hierarchical clustering on principal components (HCPC) analyses using the <italic>PCA</italic>() and <italic>HCPC</italic>() functions of the FactomineR package, respectively (<ext-link ext-link-type="uri" xlink:href="http://factominer.free.fr/">http://factominer.free.fr/</ext-link>; <xref ref-type="bibr" rid="bib31">Le et al., 2008</xref>) and graphics were generated using the Factoextra R package (<ext-link ext-link-type="uri" xlink:href="http://www.sthda.com/english/rpkgs/factoextra">http://www.sthda.com/english/rpkgs/factoextra</ext-link>; <xref ref-type="bibr" rid="bib30">Kassambara, 2017</xref>).</p></sec><sec id="s4-8"><title>TCRβ V(D)J recombination analysis</title><p><italic>Tcrb</italic> rearrangements were analyzed by PCR on genomic DNA from total adult thymocytes or E18.5 fetal thymocytes as described (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>).</p></sec><sec id="s4-9"><title>E15.5 brain sections immunohistochemistry</title><p>Neuronal apoptosis was analyzed as previously described (<xref ref-type="bibr" rid="bib1">Abramowski et al., 2018</xref>). E15.5 fetal heads were fixed overnight at 4°C by immersion in 4% paraformaldehyde and embedded in paraffin with a Tissu-tek processor (VIP, Leica). 5 μm coronal sections were then obtained using a microtome (Leica RM2125RT) and mounted onto glass slides for histological analyses. After paraffin removal and citrate treatment, the brain sections were permeabilized with 0.5% Triton X-100 in phosphate-buffered saline (PBS) for 15 min and incubated for 2 hr with 7.5% fetal bovine serum and 7.5% goat serum in PBS. The sections were incubated with rabbit anti-CC3 (Cell Signaling 9661) overnight at 4°C. After washing, the sections were incubated with goat anti-rabbit Alexa Fluor 488 or 594 conjugated secondary antibody (ThermoFisher) for 1 hr. After washing, nuclear staining was achieved by incubation with 4′-6-diamidino-2-phenylindole (DAPI) to quantify apoptosis induction by the detection of pyknotic nuclei (<xref ref-type="bibr" rid="bib46">Roque et al., 2012</xref>). Slides were mounted under Fluoromount (Southern Biotechnologies Associates). Tissues were examined under a fluorescence microscope (50i, Nikon, Japan) with a 10× (NA = 0.3) objective in three channels (appearing red, green, and gray) as separate files. These images were then stacked with Photoshop software (Adobe).</p></sec><sec id="s4-10"><title>Statistical analysis</title><p>Non-parametric Mann–Whitney test or two-tailed Fisher’s exact test was performed with α-risk = 0.05. p-Values were taken to be significant: *significant 0.05≥p&gt;0.01; **very significant 0.01≥p&gt;0.001; ***highly significant 0.001≥p&gt;0.0001; ****highly significant p≤0.0001. Using G*Power software (<ext-link ext-link-type="uri" xlink:href="https://www.psychologie.hhu.de/arbeitsgruppen/allgemeine-psychologie-und-arbeitspsychologie/gpower">https://www.psychologie.hhu.de/arbeitsgruppen/allgemeine-psychologie-und-arbeitspsychologie/gpower</ext-link>), we determined that a minimum of 47 newborns was necessary to conclude to an embryonic lethality of the <italic>Xrcc4<sup>M61R</sup>-Nhej1-/-</italic> double KO with a power of 80% and a p-value &lt; 0.05.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Conceptualization</p></fn><fn fn-type="con" id="con7"><p>Conceptualization</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Data curation, Supervision, Validation, Writing - original draft</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Validation, Writing - original draft</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experiments were performed in compliance with the French Ministry of Agriculture's regulations for animal experiments (act 87847, 19 October 1987; modified in May 2001) after audit with &quot;Comite' d'Ethique en Expe'rimentation Animale (CEEA) Paris Descartes&quot; (Apafis #25432-2019041516286014 v6).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-69353-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The xl file with raw data used in PCA analysis (Fig. 2G) has been deposited on DRYAD <ext-link ext-link-type="uri" xlink:href="https://datadryad.org/stash/share/T4vNOWxXUUGanYkI2H--C39xErpsKK6kSynXqljpxsM">https://datadryad.org/stash/share/T4vNOWxXUUGanYkI2H--C39xErpsKK6kSynXqljpxsM</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Jean-Pierre</surname><given-names>D</given-names></name><name><surname>Benoit</surname><given-names>R</given-names></name><name><surname>Vincent</surname><given-names>A</given-names></name><name><surname>Olivier</surname><given-names>E</given-names></name><name><surname>Stefania</surname><given-names>M</given-names></name><name><surname>Pierre</surname><given-names>D</given-names></name><name><surname>Jean-Baptiste</surname><given-names>C</given-names></name><name><surname>Isabelle</surname><given-names>C</given-names></name><name><surname>François</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Data from: A XRCC4 mutant mouse, a model for human X4 syndrome, reveals interplays with Xlf, PAXX, and ATM in lymphoid development</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.547d7wm7x</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by institutional grant from INSERM and Université de Paris, state funding from the Agence National de la Recherche under 'Investissements d’avenir' program (ANR-10-IAHU-01) and grants from Institut National du Cancer (PLBIO 16-280) et Ligue Nationale contre le Cancer (Equipe Labellisée). BR received fellowships from INSERM, ARC, and LNCC.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramowski</surname><given-names>V</given-names></name><name><surname>Etienne</surname><given-names>O</given-names></name><name><surname>Elsaid</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Berland</surname><given-names>A</given-names></name><name><surname>Kermasson</surname><given-names>L</given-names></name><name><surname>Roch</surname><given-names>B</given-names></name><name><surname>Musilli</surname><given-names>S</given-names></name><name><surname>Moussu</surname><given-names>J-P</given-names></name><name><surname>Lipson-Ruffert</surname><given-names>K</given-names></name><name><surname>Revy</surname><given-names>P</given-names></name><name><surname>Cumano</surname><given-names>A</given-names></name><name><surname>Boussin</surname><given-names>FD</given-names></name><name><surname>de Villartay</surname><given-names>J-P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PAXX and Xlf interplay revealed by impaired cns development and immunodeficiency of double KO mice</article-title><source>Cell Death and Differentiation</source><volume>25</volume><fpage>444</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.184</pub-id><pub-id pub-id-type="pmid">29077092</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Meng</surname><given-names>FL</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Schwer</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanisms of programmed DNA lesions and genomic instability in the immune system</article-title><source>Cell</source><volume>152</volume><fpage>417</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.01.007</pub-id><pub-id pub-id-type="pmid">23374339</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arya</surname><given-names>R</given-names></name><name><surname>Bassing</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>V(D)J Recombination Exploits DNA Damage Responses to Promote Immunity</article-title><source>Trends in Genetics</source><volume>33</volume><fpage>479</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2017.04.006</pub-id><pub-id pub-id-type="pmid">28532625</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balmus</surname><given-names>G</given-names></name><name><surname>Barros</surname><given-names>AC</given-names></name><name><surname>Wijnhoven</surname><given-names>PW</given-names></name><name><surname>Lescale</surname><given-names>C</given-names></name><name><surname>Hasse</surname><given-names>HL</given-names></name><name><surname>Boroviak</surname><given-names>K</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Synthetic lethality between PAXX and XLF in mammalian development</article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>2152</fpage><lpage>2157</lpage><pub-id pub-id-type="doi">10.1101/gad.290510.116</pub-id><pub-id pub-id-type="pmid">27798842</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>C</given-names></name><name><surname>Hirotsune</surname><given-names>S</given-names></name><name><surname>Paylor</surname><given-names>R</given-names></name><name><surname>Liyanage</surname><given-names>M</given-names></name><name><surname>Eckhaus</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>F</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Atm-deficient mice: a paradigm of ataxia telangiectasia</article-title><source>Cell</source><volume>86</volume><fpage>159</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80086-0</pub-id><pub-id pub-id-type="pmid">8689683</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>DE</given-names></name><name><surname>Stamp</surname><given-names>G</given-names></name><name><surname>Rosewell</surname><given-names>I</given-names></name><name><surname>Denzel</surname><given-names>A</given-names></name><name><surname>Lindahl</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice</article-title><source>Current Biology</source><volume>8</volume><fpage>1395</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(98)00021-9</pub-id><pub-id pub-id-type="pmid">9889105</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassing</surname><given-names>CH</given-names></name><name><surname>Swat</surname><given-names>W</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The mechanism and regulation of chromosomal V(D)J recombination</article-title><source>Cell</source><volume>109 Suppl</volume><elocation-id>S45</elocation-id><pub-id pub-id-type="doi">10.1016/s0092-8674(02)00675-x</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>C</given-names></name><name><surname>Castaneda-Zegarra</surname><given-names>S</given-names></name><name><surname>Huse</surname><given-names>C</given-names></name><name><surname>Xing</surname><given-names>M</given-names></name><name><surname>Oksenych</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mediator of DNA Damage Checkpoint Protein 1 Facilitates V(D)J Recombination in Cells Lacking DNA Repair Factor XLF</article-title><source>Biomolecules</source><volume>10</volume><elocation-id>E60</elocation-id><pub-id pub-id-type="doi">10.3390/biom10010060</pub-id><pub-id pub-id-type="pmid">31905950</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berland</surname><given-names>A</given-names></name><name><surname>Rosain</surname><given-names>J</given-names></name><name><surname>Kaltenbach</surname><given-names>S</given-names></name><name><surname>Allain</surname><given-names>V</given-names></name><name><surname>Mahlaoui</surname><given-names>N</given-names></name><name><surname>Melki</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PROMIDISalpha: A T-cell receptor alpha signature associated with immunodeficiencies caused by V(D)J recombination defects</article-title><source>The Journal of Allergy and Clinical Immunology</source><volume>143</volume><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2018.05.028</pub-id><pub-id pub-id-type="pmid">29906526</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betermier</surname><given-names>M</given-names></name><name><surname>Borde</surname><given-names>V</given-names></name><name><surname>de Villartay</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Coupling DNA Damage and Repair: an Essential Safeguard during Programmed DNA Double-Strand Breaks</article-title><source>Trends in Cell Biology</source><volume>30</volume><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2019.11.005</pub-id><pub-id pub-id-type="pmid">31818700</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>I</given-names></name><name><surname>Sitters</surname><given-names>G</given-names></name><name><surname>Candelli</surname><given-names>A</given-names></name><name><surname>Heerema</surname><given-names>SJ</given-names></name><name><surname>Heller</surname><given-names>I</given-names></name><name><surname>de Melo</surname><given-names>AJ</given-names></name><name><surname>Wuite</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sliding sleeves of XRCC4-XLF bridge DNA and connect fragments of broken DNA</article-title><source>Nature</source><volume>535</volume><fpage>566</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1038/nature18643</pub-id><pub-id pub-id-type="pmid">27437582</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buck</surname><given-names>D</given-names></name><name><surname>Malivert</surname><given-names>L</given-names></name><name><surname>de Chasseval</surname><given-names>R</given-names></name><name><surname>Barraud</surname><given-names>A</given-names></name><name><surname>Fondaneche</surname><given-names>MC</given-names></name><name><surname>Sanal</surname><given-names>O</given-names></name><name><surname>Revy</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly</article-title><source>Cell</source><volume>124</volume><fpage>287</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.12.030</pub-id><pub-id pub-id-type="pmid">16439204</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callebaut</surname><given-names>I</given-names></name><name><surname>Malivert</surname><given-names>L</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Mornon</surname><given-names>JP</given-names></name><name><surname>Revy</surname><given-names>P</given-names></name><name><surname>de Villartay</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cernunnos interacts with the XRCC4 x DNA-ligase IV complex and is homologous to the yeast nonhomologous end-joining factor Nej1</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>13857</fpage><lpage>13860</lpage><pub-id pub-id-type="doi">10.1074/jbc.C500473200</pub-id><pub-id pub-id-type="pmid">16571728</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>HHY</given-names></name><name><surname>Pannunzio</surname><given-names>NR</given-names></name><name><surname>Adachi</surname><given-names>N</given-names></name><name><surname>Lieber</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Non-homologous DNA end joining and alternative pathways to double-strand break repair</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>18</volume><fpage>495</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.48</pub-id><pub-id pub-id-type="pmid">28512351</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaplin</surname><given-names>AK</given-names></name><name><surname>Hardwick</surname><given-names>SW</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Kefala Stavridi</surname><given-names>A</given-names></name><name><surname>Hnizda</surname><given-names>A</given-names></name><name><surname>Cooper</surname><given-names>LR</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Dimers of DNA-PK create a stage for DNA double-strand break repair</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>28</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1038/s41594-020-00517-x</pub-id><pub-id pub-id-type="pmid">33077952</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaplin</surname><given-names>AK</given-names></name><name><surname>Hardwick</surname><given-names>SW</given-names></name><name><surname>Stavridi</surname><given-names>AK</given-names></name><name><surname>Buehl</surname><given-names>CJ</given-names></name><name><surname>Goff</surname><given-names>NJ</given-names></name><name><surname>Ropars</surname><given-names>V</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>De Oliveira</surname><given-names>TM</given-names></name><name><surname>Chirgadze</surname><given-names>DY</given-names></name><name><surname>Meek</surname><given-names>K</given-names></name><name><surname>Charbonnier</surname><given-names>JB</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>Cryo-em of NHEJ supercomplexes provides insights into dna repair</article-title><source>Molecular Cell</source><volume>81</volume><fpage>3400</fpage><lpage>3409</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.07.005</pub-id><pub-id pub-id-type="pmid">34352203</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Elos</surname><given-names>MT</given-names></name><name><surname>Viboolsittiseri</surname><given-names>SS</given-names></name><name><surname>Gowan</surname><given-names>K</given-names></name><name><surname>Leach</surname><given-names>SM</given-names></name><name><surname>Rice</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity</article-title><source>Journal of Hematology &amp; Oncology</source><volume>9</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1186/s13045-015-0230-5</pub-id><pub-id pub-id-type="pmid">26740101</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>BR</given-names></name><name><surname>Quinet</surname><given-names>A</given-names></name><name><surname>Byrum</surname><given-names>AK</given-names></name><name><surname>Jackson</surname><given-names>J</given-names></name><name><surname>Berti</surname><given-names>M</given-names></name><name><surname>Thangavel</surname><given-names>S</given-names></name><name><surname>Sleckman</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>XLF and H2AX function in series to promote replication fork stability</article-title><source>The Journal of Cell Biology</source><volume>218</volume><fpage>2113</fpage><lpage>2123</lpage><pub-id pub-id-type="doi">10.1083/jcb.201808134</pub-id><pub-id pub-id-type="pmid">31123184</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costantini</surname><given-names>S</given-names></name><name><surname>Woodbine</surname><given-names>L</given-names></name><name><surname>Andreoli</surname><given-names>L</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name><name><surname>Vindigni</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Interaction of the Ku heterodimer with the DNA ligase IV/Xrcc4 complex and its regulation by DNA-PK</article-title><source>DNA Repair</source><volume>6</volume><fpage>712</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2006.12.007</pub-id><pub-id pub-id-type="pmid">17241822</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craxton</surname><given-names>A</given-names></name><name><surname>Somers</surname><given-names>J</given-names></name><name><surname>Munnur</surname><given-names>D</given-names></name><name><surname>Jukes-Jones</surname><given-names>R</given-names></name><name><surname>Cain</surname><given-names>K</given-names></name><name><surname>Malewicz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>XLS (c9orf142) is a new component of mammalian DNA double-stranded break repair</article-title><source>Cell Death and Differentiation</source><volume>22</volume><fpage>890</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.22</pub-id><pub-id pub-id-type="pmid">25941166</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Villartay</surname><given-names>JP</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Durandy</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The mechanisms of immune diversification and their disorders</article-title><source>Nature Reviews. Immunology</source><volume>3</volume><fpage>962</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1038/nri1247</pub-id><pub-id pub-id-type="pmid">14647478</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Villartay</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>When natural mutants do not fit our expectations: the intriguing case of patients with XRCC4 mutations revealed by whole-exome sequencing</article-title><source>EMBO Molecular Medicine</source><volume>7</volume><fpage>862</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.15252/emmm.201505307</pub-id><pub-id pub-id-type="pmid">25962386</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>KM</given-names></name><name><surname>Sekiguchi</surname><given-names>JM</given-names></name><name><surname>Seidl</surname><given-names>KJ</given-names></name><name><surname>Swat</surname><given-names>W</given-names></name><name><surname>Rathbun</surname><given-names>GA</given-names></name><name><surname>Cheng</surname><given-names>HL</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV</article-title><source>Nature</source><volume>396</volume><fpage>173</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1038/24172</pub-id><pub-id pub-id-type="pmid">9823897</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Frank</surname><given-names>KM</given-names></name><name><surname>Dikkes</surname><given-names>P</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Seidl</surname><given-names>KJ</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis</article-title><source>Cell</source><volume>95</volume><fpage>891</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81714-6</pub-id><pub-id pub-id-type="pmid">9875844</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Ferguson</surname><given-names>DO</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Manis</surname><given-names>JP</given-names></name><name><surname>Sekiguchi</surname><given-names>J</given-names></name><name><surname>Frank</surname><given-names>KM</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development</article-title><source>Nature</source><volume>404</volume><fpage>897</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1038/35009138</pub-id><pub-id pub-id-type="pmid">10786799</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grawunder</surname><given-names>U</given-names></name><name><surname>Wilm</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Kulesza</surname><given-names>P</given-names></name><name><surname>Wilson</surname><given-names>TE</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Lieber</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells</article-title><source>Nature</source><volume>388</volume><fpage>492</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/41358</pub-id><pub-id pub-id-type="pmid">9242410</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>PJ</given-names></name><name><surname>Johnson</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>BR</given-names></name><name><surname>Byrum</surname><given-names>AK</given-names></name><name><surname>Bredemeyer</surname><given-names>AL</given-names></name><name><surname>Yewdell</surname><given-names>WT</given-names></name><name><surname>Sleckman</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining</article-title><source>Molecular Cell</source><volume>71</volume><fpage>332</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.06.018</pub-id><pub-id pub-id-type="pmid">30017584</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>D</given-names></name><name><surname>Giallourakis</surname><given-names>C</given-names></name><name><surname>Mostoslavsky</surname><given-names>R</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus</article-title><source>Annual Review of Immunology</source><volume>24</volume><fpage>541</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115830</pub-id><pub-id pub-id-type="pmid">16551259</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajikhina</surname><given-names>K</given-names></name><name><surname>Tsuneto</surname><given-names>M</given-names></name><name><surname>Melchers</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>B-Lymphopoiesis in Fetal Liver, Guided by Chemokines</article-title><source>Advances in Immunology</source><volume>132</volume><fpage>71</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/bs.ai.2016.07.002</pub-id><pub-id pub-id-type="pmid">27769508</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Kassambara</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Practical guide to cluster analysis in r</data-title><source>STHDA</source><ext-link ext-link-type="uri" xlink:href="https://xsliulab.github.io/Workshop/week10/r-cluster-book.pdf">https://xsliulab.github.io/Workshop/week10/r-cluster-book.pdf</ext-link></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>S</given-names></name><name><surname>Josse</surname><given-names>J</given-names></name><name><surname>Husson</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>FactoMineR: An R Package for Multivariate Analysis</article-title><source>Journal of Statistical Software</source><volume>25</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.18637/jss.v025.i01</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lescale</surname><given-names>C</given-names></name><name><surname>Abramowski</surname><given-names>V</given-names></name><name><surname>Bedora-Faure</surname><given-names>M</given-names></name><name><surname>Murigneux</surname><given-names>V</given-names></name><name><surname>Vera</surname><given-names>G</given-names></name><name><surname>Roth</surname><given-names>DB</given-names></name><name><surname>Deriano</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>RAG2 and XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10529</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10529</pub-id><pub-id pub-id-type="pmid">26833222</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lescale</surname><given-names>C</given-names></name><name><surname>Lenden Hasse</surname><given-names>H</given-names></name><name><surname>Blackford</surname><given-names>AN</given-names></name><name><surname>Balmus</surname><given-names>G</given-names></name><name><surname>Bianchi</surname><given-names>JJ</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Deriano</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Specific Roles of XRCC4 Paralogs PAXX and XLF during V(D)J Recombination</article-title><source>Cell Reports</source><volume>16</volume><fpage>2967</fpage><lpage>2979</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.069</pub-id><pub-id pub-id-type="pmid">27601299</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Cheng</surname><given-names>HL</given-names></name><name><surname>Brush</surname><given-names>JW</given-names></name><name><surname>Goff</surname><given-names>PH</given-names></name><name><surname>Murphy</surname><given-names>MM</given-names></name><name><surname>Zha</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination</article-title><source>Molecular Cell</source><volume>31</volume><fpage>631</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.07.017</pub-id><pub-id pub-id-type="pmid">18775323</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieber</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway</article-title><source>Annual Review of Biochemistry</source><volume>79</volume><fpage>181</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.052308.093131</pub-id><pub-id pub-id-type="pmid">20192759</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Shao</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>BJ</given-names></name><name><surname>Zha</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PAXX promotes KU accumulation at DNA breaks and is essential for end-joining in XLF-deficient mice</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>13816</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms13816</pub-id><pub-id pub-id-type="pmid">28051062</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musilli</surname><given-names>S</given-names></name><name><surname>Abramowski</surname><given-names>V</given-names></name><name><surname>Roch</surname><given-names>B</given-names></name><name><surname>de Villartay</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An in vivo study of the impact of deficiency in the DNA repair proteins PAXX and XLF on development and maturation of the hemolymphoid system</article-title><source>The Journal of Biological Chemistry</source><volume>295</volume><fpage>2398</fpage><lpage>2406</lpage><pub-id pub-id-type="doi">10.1074/jbc.AC119.010924</pub-id><pub-id pub-id-type="pmid">31915249</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochi</surname><given-names>T</given-names></name><name><surname>Blackford</surname><given-names>AN</given-names></name><name><surname>Coates</surname><given-names>J</given-names></name><name><surname>Jhujh</surname><given-names>S</given-names></name><name><surname>Mehmood</surname><given-names>S</given-names></name><name><surname>Tamura</surname><given-names>N</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>DNA repair PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair</article-title><source>Science</source><volume>347</volume><fpage>185</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1126/science.1261971</pub-id><pub-id pub-id-type="pmid">25574025</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oksenych</surname><given-names>V</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Schwer</surname><given-names>B</given-names></name><name><surname>Wesemann</surname><given-names>DR</given-names></name><name><surname>Hansen</surname><given-names>E</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Functional redundancy between repair factor XLF and damage response mediator 53BP1 in V(D)J recombination and DNA repair</article-title><source>PNAS</source><volume>109</volume><fpage>2455</fpage><lpage>2460</lpage><pub-id pub-id-type="doi">10.1073/pnas.1121458109</pub-id><pub-id pub-id-type="pmid">22308489</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Driscoll</surname><given-names>M</given-names></name><name><surname>Cerosaletti</surname><given-names>KM</given-names></name><name><surname>Girard</surname><given-names>PM</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Stumm</surname><given-names>M</given-names></name><name><surname>Kysela</surname><given-names>B</given-names></name><name><surname>Concannon</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency</article-title><source>Molecular Cell</source><volume>8</volume><fpage>1175</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(01)00408-7</pub-id><pub-id pub-id-type="pmid">11779494</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramond</surname><given-names>C</given-names></name><name><surname>Berthault</surname><given-names>C</given-names></name><name><surname>Burlen-Defranoux</surname><given-names>O</given-names></name><name><surname>de Sousa</surname><given-names>AP</given-names></name><name><surname>Guy-Grand</surname><given-names>D</given-names></name><name><surname>Vieira</surname><given-names>P</given-names></name><name><surname>Cumano</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Two waves of distinct hematopoietic progenitor cells colonize the fetal thymus</article-title><source>Nature Immunology</source><volume>15</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/ni.2782</pub-id><pub-id pub-id-type="pmid">24317038</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recio</surname><given-names>MJ</given-names></name><name><surname>Dominguez-Pinilla</surname><given-names>N</given-names></name><name><surname>Perrig</surname><given-names>MS</given-names></name><name><surname>Rodriguez Vigil-Iturrate</surname><given-names>C</given-names></name><name><surname>Salmon-Rodriguez</surname><given-names>N</given-names></name><name><surname>Martinez Faci</surname><given-names>C</given-names></name><name><surname>Gonzalez-Granado</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Extreme Phenotypes With Identical Mutations: Two Patients With Same Non-sense NHEJ1 Homozygous Mutation</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>2959</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02959</pub-id><pub-id pub-id-type="pmid">30666249</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>DA</given-names></name><name><surname>Keegan</surname><given-names>S</given-names></name><name><surname>Leo-Macias</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>G</given-names></name><name><surname>Strande</surname><given-names>NT</given-names></name><name><surname>Chang</surname><given-names>HH</given-names></name><name><surname>Rothenberg</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Organization and dynamics of the nonhomologous end-joining machinery during DNA double-strand break repair</article-title><source>PNAS</source><volume>112</volume><elocation-id>E2575</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.1420115112</pub-id><pub-id pub-id-type="pmid">25941401</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roch</surname><given-names>B</given-names></name><name><surname>Abramowski</surname><given-names>V</given-names></name><name><surname>Chaumeil</surname><given-names>J</given-names></name><name><surname>de Villartay</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cernunnos/Xlf Deficiency Results in Suboptimal V(D)J Recombination and Impaired Lymphoid Development in Mice</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>443</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00443</pub-id><pub-id pub-id-type="pmid">30923523</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ropars</surname><given-names>V</given-names></name><name><surname>Drevet</surname><given-names>P</given-names></name><name><surname>Legrand</surname><given-names>P</given-names></name><name><surname>Baconnais</surname><given-names>S</given-names></name><name><surname>Amram</surname><given-names>J</given-names></name><name><surname>Faure</surname><given-names>G</given-names></name><name><surname>Charbonnier</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural characterization of filaments formed by human Xrcc4-Cernunnos/XLF complex involved in nonhomologous DNA end-joining</article-title><source>PNAS</source><volume>108</volume><fpage>12663</fpage><lpage>12668</lpage><pub-id pub-id-type="doi">10.1073/pnas.1100758108</pub-id><pub-id pub-id-type="pmid">21768349</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roque</surname><given-names>T</given-names></name><name><surname>Haton</surname><given-names>C</given-names></name><name><surname>Etienne</surname><given-names>O</given-names></name><name><surname>Chicheportiche</surname><given-names>A</given-names></name><name><surname>Rousseau</surname><given-names>L</given-names></name><name><surname>Martin</surname><given-names>L</given-names></name><name><surname>Boussin</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lack of a p21waf1/cip -dependent G1/S checkpoint in neural stem and progenitor cells after DNA damage in vivo</article-title><source>Stem Cells</source><volume>30</volume><fpage>537</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1002/stem.1010</pub-id><pub-id pub-id-type="pmid">22162343</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Kurosawa</surname><given-names>A</given-names></name><name><surname>Adachi</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mutations in XRCC4 cause primordial dwarfism without causing immunodeficiency</article-title><source>Journal of Human Genetics</source><volume>61</volume><fpage>679</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1038/jhg.2016.46</pub-id><pub-id pub-id-type="pmid">27169690</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schatz</surname><given-names>DG</given-names></name><name><surname>Swanson</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>V(D)J recombination: mechanisms of initiation</article-title><source>Annual Review of Genetics</source><volume>45</volume><fpage>167</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-110410-132552</pub-id><pub-id pub-id-type="pmid">21854230</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shull</surname><given-names>ER</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Nakane</surname><given-names>H</given-names></name><name><surname>Stracker</surname><given-names>TH</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>HR</given-names></name><name><surname>McKinnon</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS</article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>171</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1101/gad.1746609</pub-id><pub-id pub-id-type="pmid">19171781</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibanda</surname><given-names>BL</given-names></name><name><surname>Chirgadze</surname><given-names>DY</given-names></name><name><surname>Ascher</surname><given-names>DB</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>DNA-PKcs structure suggests an allosteric mechanism modulating DNA double-strand break repair</article-title><source>Science</source><volume>355</volume><fpage>520</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1126/science.aak9654</pub-id><pub-id pub-id-type="pmid">28154079</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staines Boone</surname><given-names>AT</given-names></name><name><surname>Chinn</surname><given-names>IK</given-names></name><name><surname>Alaez-Versón</surname><given-names>C</given-names></name><name><surname>Yamazaki-Nakashimada</surname><given-names>MA</given-names></name><name><surname>Carrillo-Sánchez</surname><given-names>K</given-names></name><name><surname>García-Cruz</surname><given-names>M</given-names></name><name><surname>Poli</surname><given-names>MC</given-names></name><name><surname>González Serrano</surname><given-names>ME</given-names></name><name><surname>Medina Torres</surname><given-names>EA</given-names></name><name><surname>Muzquiz Zermeño</surname><given-names>D</given-names></name><name><surname>Forbes</surname><given-names>LR</given-names></name><name><surname>Espinosa-Rosales</surname><given-names>FJ</given-names></name><name><surname>Espinosa-Padilla</surname><given-names>SE</given-names></name><name><surname>Orange</surname><given-names>JS</given-names></name><name><surname>Lugo Reyes</surname><given-names>SO</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Failing to Make Ends Meet: The Broad Clinical Spectrum of DNA Ligase IV Deficiency Case Series and Review of the Literature</article-title><source>Frontiers in Pediatrics</source><volume>6</volume><elocation-id>426</elocation-id><pub-id pub-id-type="doi">10.3389/fped.2018.00426</pub-id><pub-id pub-id-type="pmid">30719430</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ucuncu</surname><given-names>E</given-names></name><name><surname>Rajamani</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>MSC</given-names></name><name><surname>Medina-Cano</surname><given-names>D</given-names></name><name><surname>Altin</surname><given-names>N</given-names></name><name><surname>David</surname><given-names>P</given-names></name><name><surname>Cantagrel</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>6087</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19919-y</pub-id><pub-id pub-id-type="pmid">33257696</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Burg</surname><given-names>M</given-names></name><name><surname>Gennery</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Educational paper The expanding clinical and immunological spectrum of severe combined immunodeficiency</article-title><source>European Journal of Pediatrics</source><volume>170</volume><fpage>561</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1007/s00431-011-1452-3</pub-id><pub-id pub-id-type="pmid">21479529</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera</surname><given-names>G</given-names></name><name><surname>Rivera-Munoz</surname><given-names>P</given-names></name><name><surname>Abramowski</surname><given-names>V</given-names></name><name><surname>Malivert</surname><given-names>L</given-names></name><name><surname>Lim</surname><given-names>A</given-names></name><name><surname>Bole-Feysot</surname><given-names>C</given-names></name><name><surname>de Villartay</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cernunnos deficiency reduces thymocyte life span and alters the T cell repertoire in mice and humans</article-title><source>Molecular and Cellular Biology</source><volume>33</volume><fpage>701</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1128/MCB.01057-12</pub-id><pub-id pub-id-type="pmid">23207905</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Huo</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6233</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7233</pub-id><pub-id pub-id-type="pmid">25670504</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>M</given-names></name><name><surname>Bjoras</surname><given-names>M</given-names></name><name><surname>Daniel</surname><given-names>JA</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Oksenych</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Synthetic lethality between murine DNA repair factors XLF and DNA-PKcs is rescued by inactivation of Ku70</article-title><source>DNA Repair</source><volume>57</volume><fpage>133</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2017.07.008</pub-id><pub-id pub-id-type="pmid">28759779</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Ceredig</surname><given-names>R</given-names></name><name><surname>Seoighe</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>LymAnalyzer: a tool for comprehensive analysis of next generation sequencing data of T cell receptors and immunoglobulins</article-title><source>Nucleic Acids Research</source><volume>44</volume><elocation-id>e31</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv1016</pub-id><pub-id pub-id-type="pmid">26446988</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zha</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Boboila</surname><given-names>C</given-names></name><name><surname>Oksenych</surname><given-names>V</given-names></name><name><surname>Cheng</surname><given-names>HL</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks</article-title><source>Nature</source><volume>469</volume><fpage>250</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/nature09604</pub-id><pub-id pub-id-type="pmid">21160472</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Rothenberg</surname><given-names>E</given-names></name><name><surname>Ramsden</surname><given-names>DA</given-names></name><name><surname>Lieber</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The molecular basis and disease relevance of non-homologous DNA end joining</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>21</volume><fpage>765</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-00297-8</pub-id><pub-id pub-id-type="pmid">33077885</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69353.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sen</surname><given-names>Ranjan</given-names></name><role>Reviewing Editor</role><aff><institution>National Institute on Aging</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Lieber</surname><given-names>Michael</given-names></name><role>Reviewer</role><aff><institution>University Southern California</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Rodgers</surname><given-names>Karla</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The novel mouse model described in this manuscript helps to not only clarify the role of XRCC4 in VDJ recombination and, thereby, for immune cell development but also reveals new functional interactions between XRCC4 and XLF that regulate neuronal apoptosis. The separation of function point mutation studied here demonstrates that the primary role of XRCC4 during VDJ recombination is to stabilize Lig4. This distinction also provides a ready explanation for earlier observations that humans with hypomorphic mutations in XRCC4 are not clinically immunodeficient. These insights will be broad interest to the immune development and DNA repair research communities.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;A XRCC4 mutant mouse, a model for human X4 syndrome, reveals interplays with Xlf, PAXX, and ATM in lymphoid development&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Satyajit Rath as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Michael Lieber (Reviewer #1); Karla Rodgers (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Provide a clearer and more detailed introduction to models of functions of XRCC4, XLF etc in end joining that highlights the fundamental question(s) being addressed via generation of the mouse model described in this manuscript.</p><p>2) Both reviewers list several inconsistencies in the figures, such as labeling of axes, percentages of cell populations, splenic cellularity in certain mutant mouse lines, scales in Figure 4, mean/standard deviations etc. these should be carefully checked and made uniform throughout the manuscript.</p><p>3) The protein levels of X4 and Lig4 in the double knock-out mice/embryos should be shown.</p><p>4) The Xlf-/- result is not shown in Figure 3E. Either the relevant citation needs to be included on this line, or the Xlf-/- result needs to be shown in Figure 3E.</p><p>The detailed comments from the reviewers are also appended below for providing context.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>XRCC4 deficient mouse model exhibits late embryonic lethality and defective lymphogenesis. However, no clinically significant immunodeficiency was observed in human patients with XRCC4 (X4) hypomorphic mutations, even in those with no detectable X4 in the fibroblasts. The contradictory phenomena observed in mouse and human make the roles of X4 in lymphocyte development unclear. Roch et al., developed a unique X4 mutant mouse model and investigated the roles of X4 in V(D)J recombination. The authors first generated a viable X4M61R knock-in mouse model using CRISPR/Cas9 technique. The M61R mutation disrupts the interaction between X4 and XLF, but not the interaction of X4 and LIG4. The expression of X4 protein is severely inhibited in the homozygous X4 M61R/M61R (X4M61R) mice, while LIG4 can be partially stabilized by this mutant. The separation-of-function of this mutant could help identify the functions of Lig4 stabilizing activity of X4 and the roles of X4-XLF interaction. The authors further show that MEFs from X4M61R mice show mild sensitivity to IR and phleomycin, and X4M61R does not severely affect B- and T-lymphocyte development in mice. The authors therefore suggest that the X4-XLF interaction is not critical for V(D)J recombination in vivo. The authors further investigated the functional redundancies between PAXX, ATM, and X4 in lymphoid development by generating X4M61R-PAXX-/- and X4M61R-ATM-/- double mutant mice. The X4M61R-PAXX-/- and X4M61R-ATM-/- double mutant mice exhibit impaired V(D)J recombination, causing SCID phenotype. The authors further suggest that PAXX and ATM are compensatory factors of X4M61R in immune development. The authors also introduced X4M61R on XLF-/- background mice. They found that X4M61R-XLF-/- mice experience late embryonic lethality caused by massive neuronal apoptosis, and exhibit defect in V(D)J recombination.</p><p>1. In the Introduction section, the authors propose their idea of a &quot;double DNA repair synapsis&quot; model for repair of broken ends specifically caused by RAG1/2 complex during V(D)J recombination. However, the synapsis model is not clear here. The authors might want to provide more details about the model in this section, so readers could easily understand the model. The authors suggest that RAG2, PAXX, and ATM signaling mediate the first synapse to stabilize the RAG-cut broken ends; XRCC4-XLF filaments mediate the second synapse to tether the broken ends. The &quot;two synapsis&quot; model was proposed based on the observations of functional redundancy in V(D)J recombination between XLF and RAG2, PAXX, and ATM kinase activity. In the current manuscript, the authors seek to understand the contributions of XRCC4 to this model. However, the &quot;two synapse&quot; model is not very consistent with other studies. PAXX and XLF were reported to stabilize the synaptic complex of broken ends by interacting with Ku70/Ku80 complex (PMID: 29786079, PMID: 31399561, PMID: 33289484). This suggests that PAXX and XLF have overlapping functions in mediating end synapsis, and this does not mean PAXX and XLF are within different synaptic states (first synapse and second synapse). Moreover, if XRCC4 and XLF are in the same &quot;second synapse&quot; pathway, X4M61R-XLF-/- double mutant mice then should perform V(D)J recombination to some extent; this would lead to at least modest lymphocyte development, because the &quot;first synapse&quot; by either RAG2 or ATM, or PAXX could compensate for the &quot;second synapse&quot; as suggested by the authors. But X4M61R-XLF-/- mice reported by the authors are actually immune deficiency. The interaction of XLF and XRCC4 is indeed important for end synapsis, but it does not rely on the XRCC4-XLF filament. While the results here are interesting, the authors might need to rephrase the Introduction and frame the scientific question of this manuscript in a way that reconciles the above contradictions.</p><p>2. The authors conclude that PAXX/ATM are compensatory factors for X4 in immune development based on the SCID phenotype observed in X4M61R-PAXX-/- and X4M61R-ATM-/- double mutant mice. However, the results may also suggest that PAXX/ATM are compensatory factors for XLF but not directly for X4, because M61R mutation disrupts the interaction of X4 and XLF, which might result in XLF being unable to function in the X4M61R mice.</p><p>3. In lines 69-71, the authors cite Wang's paper to support the roles of XRCC4-XLF filaments in broken DNA end synapsis. However, in the Wang paper, XRCC4 and XLF are suggested to play roles mainly at the ends of the DNA (i.e., end-to-end synapsis) rather than through a XRCC4-XLF filament structure. Moreover, the statement of &quot;X4 and PAXX binds DNA broken ends and stimulates X4-XLF DNA ends tethering in vitro&quot; is not true. PAXX alone cannot bind dsDNA (as also reported in the cited Tadi et al., 2016 paper). It is true PAXX can stimulate end-to-end synapsis and ligation (PMID: 27705800, PMID: 31399561, PMID: 29786079). The stimulation by PAXX is through the interaction with Ku70/80, but not through the XRCC4-XLF filament.</p><p>4. The authors need to carefully examine their figures and related labels and legends to make sure they are correct. For example, one label is missing on Figure 1D; the x-axis labels of Figure 1G are incorrect; Figure 1 legend, line 134, &quot;X4M61R vs X4-/- (bottom)&quot; is inconsistent with those shown on Figure 1G.</p><p>5. The percentages of specific cell populations are shown on some flow cytometry panels but not on others. The ratios of the cell populations would make the flow cytometry data easier for readers to understand.</p><p>6. In line 164, the complete loss of viability was caused by 2 but not 1 Gy as shown on Figure 1G.</p><p>7. In line 228, the cellularity of X4M61R single mutant littermates in the spleen is missing.</p><p>8. The protein levels of X4 and Lig4 in the double knock-out mice/embryos could provide more information about the roles of X4 in lymphocyte development.</p><p>9. In the Introduction, the authors should also mention and consider the substantial literature supporting end-to-end synapsis models, which involve XLF interaction with XRCC4 and Ku. Both end-to-end synapsis and X4-XLF filament formation may be occurring.</p><p>10. The authors should consider that IR (e.g., 1 Gy) produces ~30 DSB per cell, whereas during V(D)J in T or B cells, there are likely to be only a few DSB per cell. One possible explanation for the difference between DNA repair roles and V(D)J is the number of events per cell and titration out of the XLF and X4 repair factors. Also, the chemistry and structure of the DNA ends for IR (and for phleomycin) are different than for V(D)J coding ends. The authors may want to consider that this could be an important reason for the difference in repair versus V(D)J for the role of X4.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>XRCC4 (X4), a core component of the NHEJ DNA double strand break (DSB) repair pathway, functions to stabilize DNA Ligase IV (Lig4). X4 also associates with the XRCC4-like factor (Xlf) to form filaments that bridge and tether broken DNA ends. Both X4-/- and Lig4-/- mice show late embryonic lethality with massive neuronal apoptosis, as well as complete defects in V(D)J recombination. It was not known the extent that X4, aside from Lig4 stabilization, contributed to NHEJ in general DNA repair versus repair of programmed breaks during V(D)J recombination. To delineate differing functions of X4, a knock-in X4(M61R) mouse line was generated, where the M61R mutation was previously shown to disrupt interaction with Xlf while maintaining and stabilizing Lig4. A potential weakness of this model system is the reduced levels of X4(M61R) and Lig4 expression levels. Nevertheless, the overall results from this well-designed study are largely consistent with the authors' model and conclusions. Through combined genetic, immunological, and biochemical characterizations, the authors' illustrated three main points regarding X4 contributions to NHEJ. First, unlike X4-/-, X4(M61R) mice were viable with Lig4 stably expressed. Notably, while isolated X4(M61R) mouse cells showed deficiencies in repair of exogenously produced DNA DSBs, there were only relatively modest defects in B and T lymphocyte development, a marked contrast to that found with X4-/- mice. Second, The X4(M61R) mice phenocopy Xlf-/- mice by showing only minor defects in lymphocyte development, but with severe defects in V(D)J recombination when crossed with ATM or PAXX deficient mice. These results are consistent with the authors' model in which a &quot;double DNA repair synapse&quot; tethers the DNA ends in V(D)J recombination in a compensatory manner with one synapse mediated by the X4-Xlf filament and a separate synapse mediated by ATM signaling, PAXX, and the C-terminal region of RAG2. In a third point, X4(M61R) crossed with Xlf-/- mice showed late embryonic lethality due to post-mitotic neuronal apoptosis, with severe defects in V(D)J recombination in fetal hepatocytes and thymocytes. This latter point suggests that X4-Xlf filament cannot be compensated by a second DNA repair synapse in the fetal environment, perhaps due to the low expression of X4M61R. Alternatively, Xlf may function in an, as yet, unknown manner to rescue DNA repair defects of X4(M61R). In summary, using a novel separation of function X4 mutant, this study demonstrates that aside from its role in stabilizing Lig4, X4 is not requisite for B and T lymphocyte development likely due to functional redundancy of DNA end tethering in V(D)J recombination. Significantly, these results help to explain how patients with hypomorphic X4 mutations present with clear signs of DNA repair deficiency, but with no evident defects in development of the adaptive immune system.</p><p>This paper describes the development and characterization of a XRCC4 mutant mouse model, which helps to elucidate separate functions of X4 in NHEJ. Overall, this well-presented work demonstrates novel insights into the interplay between different NHEJ factors.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69353.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Provide a clearer and more detailed introduction to models of functions of XRCC4, XLF etc in end joining that highlights the fundamental question(s) being addressed via generation of the mouse model described in this manuscript.</p></disp-quote><p>The Introduction was rephrased and reorganized as requested. We added in particular 3 references of recently published articles describing the cryo-EM structure of the NHEJ core complex, thus improving our knowledge on DNA synapsis during NHEJ mediated DNA repair. We hope it increased the understanding of the scope of our study and readability of the manuscript.</p><disp-quote content-type="editor-comment"><p>2) Both reviewers list several inconsistencies in the figures, such as labeling of axes, percentages of cell populations, splenic cellularity in certain mutant mouse lines, scales in Figure 4, mean/standard deviations etc. these should be carefully checked and made uniform throughout the manuscript.</p></disp-quote><p>We carefully checked the Figures and Figure legends for mistakes and inconsistency.</p><disp-quote content-type="editor-comment"><p>3) The protein levels of X4 and Lig4 in the double knock-out mice/embryos should be shown.</p></disp-quote><p>Unfortunately, we will not be able to address this issue in a reasonable time frame. Because of the successive lockdown due to covid19 pandemic, we have been asked to sacrifice most of our living animals. Since the study was essentially finished and the manuscript was being prepared we had no choice but kill the mice related to this project.</p><disp-quote content-type="editor-comment"><p>4) The Xlf-/- result is not shown in Figure 3E. Either the relevant citation needs to be included on this line, or the Xlf-/- result needs to be shown in Figure 3E.</p></disp-quote><p>Citation has been added.</p><disp-quote content-type="editor-comment"><p>The detailed comments from the reviewers are also appended below for providing context.</p><p>Reviewer #1:</p><p>XRCC4 deficient mouse model exhibits late embryonic lethality and defective lymphogenesis. However, no clinically significant immunodeficiency was observed in human patients with XRCC4 (X4) hypomorphic mutations, even in those with no detectable X4 in the fibroblasts. The contradictory phenomena observed in mouse and human make the roles of X4 in lymphocyte development unclear. Roch et al., developed a unique X4 mutant mouse model and investigated the roles of X4 in V(D)J recombination. The authors first generated a viable X4M61R knock-in mouse model using CRISPR/Cas9 technique. The M61R mutation disrupts the interaction between X4 and XLF, but not the interaction of X4 and LIG4. The expression of X4 protein is severely inhibited in the homozygous X4 M61R/M61R (X4M61R) mice, while LIG4 can be partially stabilized by this mutant. The separation-of-function of this mutant could help identify the functions of Lig4 stabilizing activity of X4 and the roles of X4-XLF interaction. The authors further show that MEFs from X4M61R mice show mild sensitivity to IR and phleomycin, and X4M61R does not severely affect B- and T-lymphocyte development in mice. The authors therefore suggest that the X4-XLF interaction is not critical for V(D)J recombination in vivo. The authors further investigated the functional redundancies between PAXX, ATM, and X4 in lymphoid development by generating X4M61R-PAXX-/- and X4M61R-ATM-/- double mutant mice. The X4M61R-PAXX-/- and X4M61R-ATM-/- double mutant mice exhibit impaired V(D)J recombination, causing SCID phenotype. The authors further suggest that PAXX and ATM are compensatory factors of X4M61R in immune development. The authors also introduced X4M61R on XLF-/- background mice. They found that X4M61R-XLF-/- mice experience late embryonic lethality caused by massive neuronal apoptosis, and exhibit defect in V(D)J recombination.</p><p>1. In the Introduction section, the authors propose their idea of a &quot;double DNA repair synapsis&quot; model for repair of broken ends specifically caused by RAG1/2 complex during V(D)J recombination. However, the synapsis model is not clear here. The authors might want to provide more details about the model in this section, so readers could easily understand the model.</p></disp-quote><p>The Introduction was rephrased and reorganized to take into account these comment. We hope it increased the understanding of the scope of our study and readability of the manuscript.</p><disp-quote content-type="editor-comment"><p>The authors suggest that RAG2, PAXX, and ATM signaling mediate the first synapse to stabilize the RAG-cut broken ends; XRCC4-XLF filaments mediate the second synapse to tether the broken ends. The &quot;two synapsis&quot; model was proposed based on the observations of functional redundancy in V(D)J recombination between XLF and RAG2, PAXX, and ATM kinase activity. In the current manuscript, the authors seek to understand the contributions of XRCC4 to this model. However, the &quot;two synapse&quot; model is not very consistent with other studies.</p></disp-quote><p>As we mentioned in the introduction, the &quot;two synapse&quot; model is a strict specificity of the V(D)J recombination process (as opposed to random genotoxic-induced DSBs) because of the presence of the R1/2 post cleavage complex remaining on broken DNA ends as we proposed in our previous papers (Lescale et al., <italic>Nat. Com</italic>. 2016 and Betermier et al., <italic>TCB</italic> 2020). We believe it's the reason why it may appear sometimes inconsistent with purely DNA repair studies performed in vitro or <italic>in cellulo</italic> following genotoxics. The most striking inconsistency being the fact that although Xlf is a critical NHEJ factor as shown by the impressive radiosensitivity of Xlf deficient cells, the consequence on V(D)J recombination is almost null in contrast to what was well established for most NHEJ deficiencies.</p><disp-quote content-type="editor-comment"><p>PAXX and XLF were reported to stabilize the synaptic complex of broken ends by interacting with Ku70/Ku80 complex (PMID: 29786079, PMID: 31399561, PMID: 33289484). This suggests that PAXX and XLF have overlapping functions in mediating end synapsis, and this does not mean PAXX and XLF are within different synaptic states (first synapse and second synapse). Moreover, if XRCC4 and XLF are in the same &quot;second synapse&quot; pathway, X4M61R-XLF-/- double mutant mice then should perform V(D)J recombination to some extent; this would lead to at least modest lymphocyte development, because the &quot;first synapse&quot; by either RAG2 or ATM, or PAXX could compensate for the &quot;second synapse&quot; as suggested by the authors. But X4M61R-XLF-/- mice reported by the authors are actually immune deficiency. The interaction of XLF and XRCC4 is indeed important for end synapsis, but it does not rely on the XRCC4-XLF filament. While the results here are interesting, the authors might need to rephrase the Introduction and frame the scientific question of this manuscript in a way that reconciles the above contradictions.</p></disp-quote><p>The Introduction was rephrased and reorganized. We hope it increased the understanding of the scope of our study and readability of the manuscript.</p><disp-quote content-type="editor-comment"><p>2. The authors conclude that PAXX/ATM are compensatory factors for X4 in immune development based on the SCID phenotype observed in X4M61R-PAXX-/- and X4M61R-ATM-/- double mutant mice. However, the results may also suggest that PAXX/ATM are compensatory factors for XLF but not directly for X4, because M61R mutation disrupts the interaction of X4 and XLF, which might result in XLF being unable to function in the X4M61R mice.</p></disp-quote><p>We thank the Reviewer for this thought and added a sentence accordingly.</p><disp-quote content-type="editor-comment"><p>3. In lines 69-71, the authors cite Wang's paper to support the roles of XRCC4-XLF filaments in broken DNA end synapsis. However, in the Wang paper, XRCC4 and XLF are suggested to play roles mainly at the ends of the DNA (i.e., end-to-end synapsis) rather than through a XRCC4-XLF filament structure. Moreover, the statement of &quot;X4 and PAXX binds DNA broken ends and stimulates X4-XLF DNA ends tethering in vitro&quot; is not true. PAXX alone cannot bind dsDNA (as also reported in the cited Tadi et al., 2016 paper). It is true PAXX can stimulate end-to-end synapsis and ligation (PMID: 27705800, PMID: 31399561, PMID: 29786079). The stimulation by PAXX is through the interaction with Ku70/80, but not through the XRCC4-XLF filament.</p></disp-quote><p>The Introduction was rephrased and reorganized to take into account these comment. We hope it increased the understanding of the scope of our study and readability of the manuscript.</p><disp-quote content-type="editor-comment"><p>4. The authors need to carefully examine their figures and related labels and legends to make sure they are correct. For example, one label is missing on Figure 1D; the x-axis labels of Figure 1G are incorrect; Figure 1 legend, line 134, &quot;X4M61R vs X4-/- (bottom)&quot; is inconsistent with those shown on Figure 1G.</p></disp-quote><p>We carefully checked the Figures and Figure legends for mistakes and inconsistency.</p><disp-quote content-type="editor-comment"><p>5. The percentages of specific cell populations are shown on some flow cytometry panels but not on others. The ratios of the cell populations would make the flow cytometry data easier for readers to understand.</p></disp-quote><p>The % of cell population was shown only on Fig2D. For consistency with all other FACS panel we removed the % values on Fig2D. The actual values of gated cell population are computed on side histograms.</p><p>As suggested, we tried representation of the data by ratio rather than true values. As shown in <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref> on two examples, we believe that the ratio representation (right) makes the data less readable in addition to losing the information of the real numbers (left) as it compresses the differences. We decided to keep data representation as it was<italic>.</italic></p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69353-sa2-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>6. In line 164, the complete loss of viability was caused by 2 but not 1 Gy as shown on Figure 1G.</p></disp-quote><p>Corrected.</p><disp-quote content-type="editor-comment"><p>7. In line 228, the cellularity of X4M61R single mutant littermates in the spleen is missing.</p></disp-quote><p>Mean+/-SEM were checked for consistency.</p><disp-quote content-type="editor-comment"><p>8. The protein levels of X4 and Lig4 in the double knock-out mice/embryos could provide more information about the roles of X4 in lymphocyte development.</p></disp-quote><p>Unfortunately, we will not be able to address this issue in a reasonable time frame. Because of the successive lockdown due to covid19 pandemic, we have been asked to sacrifice most of our living animals. Since the study was essentially finished and the manuscript was being prepared we had no choice but kill the mice related to this project.</p><disp-quote content-type="editor-comment"><p>9. In the Introduction, the authors should also mention and consider the substantial literature supporting end-to-end synapsis models, which involve XLF interaction with XRCC4 and Ku. Both end-to-end synapsis and X4-XLF filament formation may be occurring.</p></disp-quote><p>We added a paragraph on DNA end synapsis with reference to Zhao et al., for further detailed reading and the 3 references on resolution of NHEJ core complexes through cryo-EM.</p><disp-quote content-type="editor-comment"><p>10. The authors should consider that IR (e.g., 1 Gy) produces ~30 DSB per cell, whereas during V(D)J in T or B cells, there are likely to be only a few DSB per cell. One possible explanation for the difference between DNA repair roles and V(D)J is the number of events per cell and titration out of the XLF and X4 repair factors. Also, the chemistry and structure of the DNA ends for IR (and for phleomycin) are different than for V(D)J coding ends. The authors may want to consider that this could be an important reason for the difference in repair versus V(D)J for the role of X4.</p></disp-quote><p>We agree that there are major qualitative and quantitative differences beetween VDJ and IR generated DSBs. Nevertheless, again taking Xlf deficiency as an example the one V(D)J break is repaired in Xlf KO mice but not anymore in many Xlf/NHEJ (or RAG2<sup>cc</sup>) double KO conditions. So we do not think that the number of breaks or their nature is the central issue, but rather the existence of a V(D)J specific backup system for the repair of prDSB.</p></body></sub-article></article>